<div id="page0" style="width:595.3pt;height:793.7pt">
<p style="top:93.6pt;left:57.7pt;line-height:17.9pt"><span style="font-family:AdvPSA88B,serif;font-size:17.9pt">Cell Therapy, a Novel Remedy for Dilated Cardiomyopathy?</span></p>
<p style="top:115.5pt;left:213.6pt;line-height:17.9pt"><span style="font-family:AdvPSA88B,serif;font-size:17.9pt">A Systematic Review</span></p>
<p style="top:152.4pt;left:109.0pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">JOHANNES M.I.H. GHO, MD,</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">GIJS J.M. KUMMELING, MD,</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt">,</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">2</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">STEFAN KOUDSTAAL, MD,</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt">,</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">2</span></sup></p>
<p style="top:163.3pt;left:44.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">SANNE J. JANSEN OF LORKEERS, MD,</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">PIETER A. DOEVENDANS, MD, PhD,</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt">,</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">2</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">FOLKERT W. ASSELBERGS, MD, PhD,</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt">,</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">2</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">AND</span></p>
<p style="top:174.3pt;left:215.0pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">STEVEN A.J. CHAMULEAU, MD, PhD</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt">,</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">2</span></sup></p>
<p style="top:193.0pt;left:254.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88C,serif;font-size:8.0pt">Utrecht, The Netherlands</span></p>
<p style="top:234.5pt;left:271.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">ABSTRACT</span></p>
<p style="top:252.4pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Background:</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Dilated cardiomyopathy (DCM) is the most common form of nonischemic cardiomyopathy</span></p>
<p style="top:263.4pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">worldwide and can lead to sudden cardiac death and heart failure. Despite ongoing advances made in the</span></p>
<p style="top:274.3pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">treatment of DCM, improvement of outcome remains problematic. Stem cell therapy has been extensively</span></p>
<p style="top:285.2pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">studied in preclinical and clinical models of ischemic heart disease, showing potential bene&#xfb01;t. DCM is</span></p>
<p style="top:296.2pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">associated with a major health burden, and few studies have been performed on cell therapy for DCM.</span></p>
<p style="top:307.2pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">In this systematic review we aimed to provide an overview of preclinical and clinical studies performed</span></p>
<p style="top:318.1pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">on cell therapy for DCM.</span></p>
<p style="top:329.1pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Methods and Results:</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> A systematic search, critical appraisal, and summarized outcomes are presented.</span></p>
<p style="top:340.1pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">In total, 29 preclinical and 15 clinical studies were included. Methodologic quality of reported studies in</span></p>
<p style="top:351.0pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">general was low based on the Centre for Evidence Based Medicine, Oxford University, criteria. A large</span></p>
<p style="top:362.0pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">heterogeneity in inclusion criteria, procedural characteristics, and outcome measures was noted. The ma-</span></p>
<p style="top:372.9pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">jority of studies showed a signi&#xfb01;cant increase in left ventricular ejection fraction after cell therapy during</span></p>
<p style="top:383.9pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">follow-up.</span></p>
<p style="top:394.8pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Conclusions:</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Stem cell therapy has shown moderate but signi&#xfb01;cant effects in clinical trials for ischemic</span></p>
<p style="top:405.8pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">heart disease, but it remains to be determined if we can extrapolate these results to DCM patients. There is</span></p>
<p style="top:416.8pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">a need for methodologically sound studies to elucidate underlying mechanisms and translate those into</span></p>
<p style="top:427.7pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">improved therapy for clinical practice. To validate safety and ef&#xfb01;cacy of cell therapy for DCM, adequate</span></p>
<p style="top:438.7pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">randomized (placebo) controlled trials using different strategies are mandatory. (</span><span style="font-family:AdvPSA88C,serif;font-size:9.0pt">J Cardiac Fail</span></p>
<p style="top:449.6pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88C,serif;font-size:9.0pt">2013;19:494</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt">e</span><span style="font-family:AdvPSA88C,serif;font-size:9.0pt">502</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">)</span></p>
<p style="top:460.6pt;left:103.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Key Words:</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> DCM, nonischemic cardiomyopathy, heart failure, stem cells.</span></p>
<p style="top:508.0pt;left:54.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Dilated cardiomyopathy (DCM) is the most common</span></p>
<p style="top:520.0pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">form of nonischemic cardiomyopathy worldwide.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">1</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Esti-</span></p>
<p style="top:532.0pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">mated prevalence in adults is 1/2,500 individuals, with an</span></p>
<p style="top:543.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">incidence of 7/100,000 per year. It is de&#xfb01;ned by dilation</span></p>
<p style="top:555.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and impaired contraction of heart muscle in the absence</span></p>
<p style="top:567.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">of an obvious etiology such as ischemic heart disease or</span></p>
<p style="top:579.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">valve disease. Causes are multifactorial, including genetics</span></p>
<p style="top:591.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">as a major contributor. DCM can lead to sudden cardiac</span></p>
<p style="top:508.1pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">death and heart failure, and carries a heavy burden on</span></p>
<p style="top:520.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">health care resources owing to a high rate of hospital admis-</span></p>
<p style="top:532.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sion and occasional need for ventricular assist device and/or</span></p>
<p style="top:543.9pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">heart transplantation. Over the past years, progress has been</span></p>
<p style="top:555.9pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">made in treating DCM, but improving outcome remains</span></p>
<p style="top:567.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">a dif&#xfb01;cult goal to achieve.</span></p>
<p style="top:579.8pt;left:317.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Stem cell therapy for cardiac repair has been extensively</span></p>
<p style="top:591.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studied in acute myocardial infarction and chronic ischemic</span></p>
<p style="top:640.2pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88C,serif;font-size:8.0pt">From the</span><span style="font-family:AdvPSA88C,serif;font-size:5.6pt"> </span><sup><span style="font-family:AdvPSA88C,serif;font-size:5.6pt">1</span></sup><span style="font-family:AdvPSA88C,serif;font-size:8.0pt">Department of Cardiology, Division Heart &amp; Lungs, Univer-</span></p>
<p style="top:649.2pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88C,serif;font-size:8.0pt">sity Medical Center, Utrecht, The Netherlands and</span><span style="font-family:AdvPSA88C,serif;font-size:5.6pt"> </span><sup><span style="font-family:AdvPSA88C,serif;font-size:5.6pt">2</span></sup><span style="font-family:AdvPSA88C,serif;font-size:8.0pt">Interuniversity Cardi-</span></p>
<p style="top:658.2pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88C,serif;font-size:8.0pt">ology Institute of the Netherlands (ICIN), Utrecht, The Netherlands.</span></p>
<p style="top:667.1pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Manuscript received September 16, 2012; revised manuscript received</span></p>
<p style="top:676.1pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">May 9, 2013; revised manuscript accepted May 13, 2013.</span></p>
<p style="top:685.1pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Reprint requests: Johannes M.I.H. Gho, MD, Department of Cardiology,</span></p>
<p style="top:694.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Division Heart &amp; Lungs, University Medical Center Utrecht, Room</span></p>
<p style="top:703.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">E03.511, PO Box 85500, 3508 GA Utrecht, The Netherlands. Tel:</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">31</span></p>
<p style="top:712.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">88 7555555; Fax:</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">31 88 7555660. E-mail:</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> jgho@umcutrecht.nl</span></p>
<p style="top:720.9pt;left:51.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Funding: HGG Group (Wieringerwerf, The Netherlands) and Wijnand</span></p>
<p style="top:729.9pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">M. Pon Foundation (Leusden, The Netherlands). This research forms</span></p>
<p style="top:640.3pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">part of the Project P1.04 SMARTCARE of the research program of the</span></p>
<p style="top:649.2pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BioMedical Materials Institute, co-funded by the Dutch Ministry of Eco-</span></p>
<p style="top:658.2pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">nomic Affairs, Agriculture, and Innovation. The &#xfb01;nancial contribution of</span></p>
<p style="top:667.1pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">the Nederlandse Hartstichting is gratefully acknowledged. Folkert W. As-</span></p>
<p style="top:676.1pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">selbergs is supported by a clinical fellowship from the Netherlands Orga-</span></p>
<p style="top:685.1pt;left:307.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">nisation for Health Research and Development (ZonMw grant 90700342).</span></p>
<p style="top:694.1pt;left:314.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">See page 500 for disclosure information.</span></p>
<p style="top:703.0pt;left:315.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1071-9164/$ - see front matter</span></p>
<p style="top:712.0pt;left:315.1pt;line-height:8.0pt"><span style="font-family:AdvPSSym,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88C,serif;font-size:8.0pt"> 2013 Elsevier Inc. All rights reserved.</span></p>
<p style="top:721.0pt;left:315.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">http://dx.doi.org/10.1016/j.cardfail.2013.05.006</span></p>
<p style="top:758.2pt;left:286.9pt;line-height:10.0pt"><span style="font-family:Arial,serif;font-size:10.0pt">494</span></p>
<p style="top:34.9pt;left:363.7pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt;color:#000066">Journal of Cardiac Failure Vol. 19 No. 7 2013</span></p>


<p style="top:58.7pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">heart disease, showing potential bene&#xfb01;t.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">2</span></sup><sup><span style="font-family:AdvPS44A44B,serif;font-size:7.0pt;color:#000066">e</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">4</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Proposed work-</span></p>
<p style="top:70.7pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ing mechanisms include, e.g., transdifferentiation of stem</span></p>
<p style="top:82.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cells to cardiomyocytes, activation of intrinsic cardiac</span></p>
<p style="top:94.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">stem cells, paracrine effects, and angiogenesis. Only</span></p>
<p style="top:106.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">a few studies have been reported on cell therapy for</span></p>
<p style="top:118.5pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">DCM, with human trials since 2006. To the best of our</span></p>
<p style="top:130.5pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">knowledge, no complete overview has been reported so</span></p>
<p style="top:142.4pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">far. In the present systematic review, preclinical and clinical</span></p>
<p style="top:154.4pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studies on cell therapy for DCM are reported, including val-</span></p>
<p style="top:166.3pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">idity,</span></p>
<p style="top:166.3pt;left:76.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">procedural</span></p>
<p style="top:166.3pt;left:127.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">characteristics,</span></p>
<p style="top:166.3pt;left:195.6pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">safety,</span></p>
<p style="top:166.3pt;left:229.7pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and</span></p>
<p style="top:166.3pt;left:252.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">outcome</span></p>
<p style="top:178.3pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">measures.</span></p>
<p style="top:209.0pt;left:146.8pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Methods</span></p>
<p style="top:226.7pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">Data Collection and Analysis</span></p>
<p style="top:244.6pt;left:56.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">We searched PubMed and Embase for reports of preclinical (all</span></p>
<p style="top:255.5pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">years) and clinical (2006</span><span style="font-family:AdvPS44A44B,serif;font-size:9.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">2012) therapeutic studies on various</span></p>
<p style="top:266.5pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">types of cell therapy for nonischemic DCM (search syntaxes are</span></p>
<p style="top:277.5pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">provided in</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt;color:#000066"> Supplemental Tables 1 and 2</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">). To prevent selection</span></p>
<p style="top:288.4pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">and retrieval bias, outcome was not included in the search syn-</span></p>
<p style="top:299.4pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">taxes. Only English- and German-language articles were included,</span></p>
<p style="top:310.4pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">and no restrictions were imposed on timing of assessment and</span></p>
<p style="top:321.3pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">follow-up. Excluded were abstracts, reviews, reports from scien-</span></p>
<p style="top:332.2pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">ti&#xfb01;c sessions and discussions, case reports, in vitro studies, studies</span></p>
<p style="top:343.2pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">only on ischemic heart disease, pediatric studies, and articles de-</span></p>
<p style="top:354.2pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">scribing study design. Retrieved studies were used for cross-</span></p>
<p style="top:365.1pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">reference checking and carefully examined to exclude potentially</span></p>
<p style="top:376.1pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">duplicate or overlapping data. Reviews and case reports were</span></p>
<p style="top:387.1pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">available for background information. A separate search was per-</span></p>
<p style="top:398.0pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">formed on</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt;color:#000066"> ClinicalTrials.gov</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> for ongoing trials (</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt;color:#000066">Supplemental</span></p>
<p style="top:408.9pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt;color:#000066">Table 3</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">). Authors were contacted for missing data.</span></p>
<p style="top:434.6pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">Assessment of Quality and Risk of Bias</span></p>
<p style="top:452.6pt;left:56.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">For assessment of quality, risk of bias (e.g., selection or infor-</span></p>
<p style="top:463.5pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">mation bias), and heterogeneity, remaining articles were consid-</span></p>
<p style="top:474.5pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">ered for critical appraisal. Quality of studies were assessed in</span></p>
<p style="top:485.5pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">duplicate (by G.K. and J.G.) with the use of standard forms for rel-</span></p>
<p style="top:496.4pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">evance and validity according to the Centre for Evidence Based</span></p>
<p style="top:507.3pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Medicine, Oxford University, criteria.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:6.3pt;color:#000066">5</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Study design was deter-</span></p>
<p style="top:518.3pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">mined, and adequate randomization (concealed allocation) or</span></p>
<p style="top:529.3pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">comparable groups when not randomized, losses to follow-up,</span></p>
<p style="top:540.3pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">and blinding of physician/treatment of&#xfb01;cer or researcher were</span></p>
<p style="top:551.2pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">reviewed.</span></p>
<p style="top:576.9pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">Data Extraction and Management</span></p>
<p style="top:594.8pt;left:56.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Study characteristics and used outcome measures were summa-</span></p>
<p style="top:605.8pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">rized. If necessary, data were estimated graphically or calculated</span></p>
<p style="top:616.7pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">with standard deviations from available data with the use of</span></p>
<p style="top:627.7pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">SPSS 17.0 (Chicago, Illinois). Two-tailed</span><span style="font-family:AdvPSA88C,serif;font-size:9.0pt"> P</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> values</span><span style="font-family:AdvPS4731B1,serif;font-size:9.0pt"> !</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">.05 were</span></p>
<p style="top:638.7pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">considered to be signi&#xfb01;cant.</span></p>
<p style="top:668.5pt;left:149.4pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Results</span></p>
<p style="top:686.2pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">Preclinical Studies</span></p>
<p style="top:704.4pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Literature Search.</span></p>
<p style="top:704.4pt;left:153.0pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Our preclinical search yielded</span></p>
<p style="top:716.3pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">1,455 unique articles (</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Fig. 1</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). After screening of title and</span></p>
<p style="top:728.3pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">abstract with the use of inclusion and exclusion criteria,</span></p>
<p style="top:58.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">29 relevant articles remained; reference checking retrieved</span></p>
<p style="top:70.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">no new articles.</span></p>
<p style="top:82.6pt;left:322.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Study</span></p>
<p style="top:82.6pt;left:357.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Characteristics</span></p>
<p style="top:82.6pt;left:431.6pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">and</span></p>
<p style="top:82.6pt;left:457.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Quality</span></p>
<p style="top:82.6pt;left:498.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Assessment.</span></p>
<p style="top:94.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Quality</span></p>
<p style="top:94.6pt;left:349.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">assessment</span></p>
<p style="top:94.6pt;left:401.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">of</span></p>
<p style="top:94.6pt;left:418.3pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">included</span></p>
<p style="top:94.6pt;left:461.0pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studies</span></p>
<p style="top:94.6pt;left:497.0pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">is</span></p>
<p style="top:94.6pt;left:512.3pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">presented</span></p>
<p style="top:106.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">in</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066"> Supplemental Table 4</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">. In summary, about one-half (15/</span></p>
<p style="top:118.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">29) were conducted in a randomized fashion; 1 study (Jin</span></p>
<p style="top:130.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al.) reported allocation concealment.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">6</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">One study reported</span></p>
<p style="top:142.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">blinding of the treatment of&#xfb01;cer.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">7</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Twelve studies reported</span></p>
<p style="top:154.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">blinding of the effect investigators for treatment. All relevant</span></p>
<p style="top:166.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">data of the 29 studies are presented in</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066"> Table 1</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">. Two studies</span></p>
<p style="top:178.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">used a large animal model (Hata et al: dogs; Psaltis et al:</span></p>
<p style="top:190.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sheep); all other studies used rodent or rabbit models.</span></p>
<p style="top:202.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Delivery route varied between intracoronary or intravenous</span></p>
<p style="top:214.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">infusion, intramuscular injection, sheet graft, or surgical in-</span></p>
<p style="top:226.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">jections, and in total 10 different stem cell types were</span></p>
<p style="top:238.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">used. Fractional shortening, fractional area change, and ejec-</span></p>
<p style="top:250.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">tion fraction were determined by 2-dimensional echocardi-</span></p>
<p style="top:262.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ography in almost all of the studies; only Psaltis et al used</span></p>
<p style="top:273.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">magnetic resonance imaging (MRI) to determine ejection</span></p>
<p style="top:285.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">fraction. Delta pressure/delta time and peak systolic pressure</span></p>
<p style="top:297.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">were measured with the use of hemodynamic measurements.</span></p>
<p style="top:309.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Five studies reported baseline data, showing no signi&#xfb01;cant</span></p>
<p style="top:321.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">differences in the study groups. Twenty-one out of 29 studies</span></p>
<p style="top:333.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">had suf&#xfb01;cient and comparable proportions of follow-up, and</span></p>
<p style="top:345.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">length of follow-up varied from 2 to 21 weeks. Lin et al, Sun</span></p>
<p style="top:357.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al, and Kondoh et al (2006 and 2007) reported interim re-</span></p>
<p style="top:369.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sults on ejection fraction or fractional shortening. Most stud-</span></p>
<p style="top:381.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ies (24/29) used comparable treatment methods between</span></p>
<p style="top:393.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">control and therapy groups. Eighteen out of 29 studies</span></p>
<p style="top:405.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">(62%) were published in a journal with impact factor</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt"> $</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">3.00.</span></p>
<p style="top:417.5pt;left:322.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Ef&#xfb01;cacy and Safety in Animal Models.</span></p>
<p style="top:417.5pt;left:505.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">All animal</span></p>
<p style="top:429.4pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studies demonstrated a positive effect of stem cell therapy</span></p>
<p style="top:441.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">on left ventricular function, of which 24 studies showed sig-</span></p>
<p style="top:453.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ni&#xfb01;cant improvement, ranging from 3.0% to 24% on echo-</span></p>
<p style="top:465.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cardiographic evaluation (</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Table 1</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). In general, no safety</span></p>
<p style="top:477.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">issues were found in these studies. Of 18 studies that as-</span></p>
<p style="top:489.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sessed mortality, 3 found improvement in survival.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">8</span></sup><sup><span style="font-family:AdvPS44A44B,serif;font-size:7.0pt;color:#000066">e</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">10</span></sup></p>
<p style="top:501.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Ten studies found equal mortality between treatment and</span></p>
<p style="top:513.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">control groups, other studies did not mention signi&#xfb01;cance,</span></p>
<p style="top:524.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and no cardiac tamponade was reported. Four studies de-</span></p>
<p style="top:536.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">tected no arrhythmias; other studies did not mention any</span></p>
<p style="top:548.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">occurrence of arrhythmias.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">10</span></sup><sup><span style="font-family:AdvPS44A44B,serif;font-size:7.0pt;color:#000066">e</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">13</span></sup></p>
<p style="top:578.6pt;left:310.8pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">Clinical Studies</span></p>
<p style="top:596.8pt;left:322.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Literature</span></p>
<p style="top:596.8pt;left:376.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Search.</span></p>
<p style="top:596.8pt;left:418.7pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Our</span></p>
<p style="top:596.8pt;left:443.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">clinical</span></p>
<p style="top:596.8pt;left:483.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">search</span></p>
<p style="top:596.8pt;left:518.3pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">strategy</span></p>
<p style="top:608.7pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">yielded 339 unique hits (</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Fig. 2</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). Screening of title and ab-</span></p>
<p style="top:620.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">stract using inclusion and exclusion criteria resulted in 16</span></p>
<p style="top:632.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">relevant articles. One relevant peer-reviewed article was</span></p>
<p style="top:644.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">found not indexed on PubMed or Embase.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">14</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">All principle</span></p>
<p style="top:656.6pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">investigators from ongoing trials were contacted for up-</span></p>
<p style="top:668.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">to-date trial results (see Ongoing Clinical Trials, below),</span></p>
<p style="top:680.5pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">this resulted in 2 additional complete manuscripts.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">15,16</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Ref-</span></p>
<p style="top:692.4pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">erence checking retrieved no new articles. Four articles</span></p>
<p style="top:704.4pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">were excluded because of overlapping data. In total, 15 ar-</span></p>
<p style="top:716.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ticles were considered for critical appraisal (4 randomized</span></p>
<p style="top:728.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">controlled trials [RCTs], 2 non-RCTs, 9 cohort studies).</span></p>
<p style="top:34.9pt;left:298.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Cell Therapy for Dilated Cardiomyopathy</span><span style="font-family:AdvP4C4E74,serif;font-size:13.0pt"> &#xfffd;</span></p>
<p style="top:34.9pt;left:486.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Gho et al</span></p>
<p style="top:34.2pt;left:533.4pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">495</span></p>


<p style="top:321.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Authors were contacted for articles not available in full text</span></p>
<p style="top:333.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and missing data (8 authors responded).</span></p>
<p style="top:345.7pt;left:56.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Study</span></p>
<p style="top:345.7pt;left:90.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Characteristics</span></p>
<p style="top:345.7pt;left:164.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">and</span></p>
<p style="top:345.7pt;left:190.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Quality</span></p>
<p style="top:345.7pt;left:232.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Assessment.</span></p>
<p style="top:357.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Four out of 15 studies were randomized; 2 nonRCTs used</span></p>
<p style="top:369.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">matched control groups (</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Table 2</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">).</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066"> Supplemental Table 5</span></p>
<p style="top:381.6pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">presents further methodologic quality of the included stud-</span></p>
<p style="top:393.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ies. Allocation concealment was not reported in the RCTs.</span></p>
<p style="top:405.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">There was no patient or physician blinding performed in</span></p>
<p style="top:417.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">these clinical studies, nor placebo used in the controlled tri-</span></p>
<p style="top:429.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">als. Two of the controlled trials described equally treated</span></p>
<p style="top:441.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">groups aside from the allocated treatment.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">17,18</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Losses to</span></p>
<p style="top:453.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">follow-up were reported and adequate (</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt">#</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">20%) in 13</span></p>
<p style="top:465.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">out of 15 studies. All articles were published in peer-</span></p>
<p style="top:477.2pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">reviewed journals, 5 (33%) of the 15 studies in a journal</span></p>
<p style="top:489.2pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">with impact factor</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt"> $</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">3.00.</span></p>
<p style="top:501.1pt;left:54.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Sample size ranged from 3 to 131 persons and overall</span></p>
<p style="top:513.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">follow-up duration from 3 to 60 months. De&#xfb01;nitions used</span></p>
<p style="top:525.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">for dilated cardiomyopathy were different between studies.</span></p>
<p style="top:537.0pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Seven studies reported excluding patients with coronary</span></p>
<p style="top:549.0pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">artery disease on coronary angiography.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">14,16,18</span></sup><sup><span style="font-family:AdvPS44A44B,serif;font-size:7.0pt;color:#000066">e</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">22</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Only</span></p>
<p style="top:560.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Schannwell et al performed endomyocardial biopsy in all</span></p>
<p style="top:572.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">patients to exclude myocarditis; Seth et al performed biop-</span></p>
<p style="top:584.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sies in 8/85 patients. Three studies included patients with</span></p>
<p style="top:596.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ischemic cardiomyopathy in a separate group; those</span></p>
<p style="top:608.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">subgroups were excluded for this review.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">14,23,24</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">For Fat-</span></p>
<p style="top:620.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">khutdinov et al, the groups undergoing concomitant (valve)</span></p>
<p style="top:632.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">surgery also were excluded. For cell delivery, the majority</span></p>
<p style="top:644.6pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">used an intracoronary route versus a surgical procedure</span></p>
<p style="top:656.6pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">with intramyocardial injections (11 vs 4). Cell type was dif-</span></p>
<p style="top:668.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ferent between studies: Mostly bone marrow stem cells</span></p>
<p style="top:680.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">were used; 2 studies used fetal material. Kirillov et al had</span></p>
<p style="top:692.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">1 group with prenatal allogenic skeletal myoblasts and 1</span></p>
<p style="top:704.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">with prenatal mesenchymal stem cells.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">25</span></sup></p>
<p style="top:716.3pt;left:56.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Ef&#xfb01;cacy Outcomes in Clinical Trials.</span></p>
<p style="top:716.3pt;left:239.2pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Main out-</span></p>
<p style="top:728.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">comes reported in clinical trials were left ventricular</span></p>
<p style="top:321.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ejection fraction (LVEF), New York Heart Association</span></p>
<p style="top:333.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">(NYHA) functional class, quality of life (QoL), and mortal-</span></p>
<p style="top:345.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ity. All but 1 article mainly used 2-dimensional echocardi-</span></p>
<p style="top:357.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ography for determining ejection fraction; Fischer-Rasokat</span></p>
<p style="top:369.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al used angiography.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">26</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Cardiac MRI was only used in</span></p>
<p style="top:381.6pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">certain subgroups. Mean differences in LVEF between</span></p>
<p style="top:393.5pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">baseline and &#xfb01;nal follow-up values are presented in</span></p>
<p style="top:405.5pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Table 2</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> (baseline and &#xfb01;nal LVEF values are presented in</span></p>
<p style="top:417.5pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Supplemental Table 6</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). LVEF values were calculated for</span></p>
<p style="top:429.4pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Arg</span><span style="font-family:AdvP4C4E59,serif;font-size:10.0pt">&#x20ac;</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">uero et al from available patient data; LVEF was esti-</span></p>
<p style="top:441.4pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">mated in the therapy groups of Fatkhutdinov et al and the</span></p>
<p style="top:453.4pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">control groups of Vrtovec et al (2011 and 2013), because</span></p>
<p style="top:465.3pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">these were only graphically depicted. The majority of stud-</span></p>
<p style="top:477.2pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ies (10/15) showed a signi&#xfb01;cant increase in LVEF in the</span></p>
<p style="top:489.2pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">therapy group (range 3.2% to 11%). Four studies found</span></p>
<p style="top:501.2pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">no signi&#xfb01;cant difference between baseline and follow-up</span></p>
<p style="top:513.1pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">in the therapy groups.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">17,20,24,25</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Kalil et al showed a signi&#xfb01;-</span></p>
<p style="top:525.1pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cant decrease of 0.5% (</span><span style="font-family:AdvPSA88C,serif;font-size:10.0pt">P</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt"> 5</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> .023) in mean ejection fraction</span></p>
<p style="top:537.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">at &#xfb01;nal follow-up (12 mo); in that study, LVEF increased in</span></p>
<p style="top:549.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">the &#xfb01;rst 2 months after surgical cell therapy but decreased</span></p>
<p style="top:561.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">afterward. In the control groups, increase of mean LVEF</span></p>
<p style="top:572.9pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">from baseline was less or LVEF decreased (range from</span></p>
<p style="top:584.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">about</span><span style="font-family:AdvP4C4E74,serif;font-size:10.0pt"> &#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">5% to 5.6%). The highest increase was found in</span></p>
<p style="top:596.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">the control group of Bocchi et al, which underwent granu-</span></p>
<p style="top:608.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">locyte colony</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">stimulating factor administration. Seth et al</span></p>
<p style="top:620.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">showed a signi&#xfb01;cant difference (</span><span style="font-family:AdvPSA88C,serif;font-size:10.0pt">P</span><span style="font-family:AdvPS4731B1,serif;font-size:10.0pt"> !</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> .05) between therapy</span></p>
<p style="top:632.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and control groups (LVEF 5.9% vs 0.4%), and Vrtovec et al</span></p>
<p style="top:644.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">found a signi&#xfb01;cant change in LVEF mean difference in both</span></p>
<p style="top:656.6pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studies.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">15,21,22</span></sup></p>
<p style="top:668.5pt;left:317.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">NYHA functional class improved in all 9 studies that re-</span></p>
<p style="top:680.5pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ported functional class, with signi&#xfb01;cant improvements in</span></p>
<p style="top:692.4pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">more than one-half of them.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">14,17,19,20,27</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">QoL was deter-</span></p>
<p style="top:704.4pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">mined with the use of questionnaires and reported to be sig-</span></p>
<p style="top:716.3pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ni&#xfb01;cantly improved in 6 studies.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">14,19</span></sup><sup><span style="font-family:AdvPS44A44B,serif;font-size:7.0pt;color:#000066">e</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">21,27,28</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Fatkhutdinov</span></p>
<p style="top:728.3pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al found an improvement in QoL at 3 months during</span></p>
<img style="position:absolute;transform:matrix(.31995527,0,-0,.31969584,-306.406,-207.8686)" src="data:image/jpeg;base64,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">
<p style="top:272.1pt;left:78.6pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Fig. 1.</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Flowchart of search strategy preclinical studies. ENG, English; GER, German; DCM, dilated cardiomyopathy.</span></p>
<p style="top:34.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">496</span></p>
<p style="top:35.7pt;left:70.1pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Journal of Cardiac Failure Vol. 19 No. 7 July 2013</span></p>


<p style="top:501.1pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">follow-up, but at &#xfb01;nal follow-up the difference was</span></p>
<p style="top:513.1pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">nonsigni&#xfb01;cant.</span></p>
<p style="top:525.1pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Safety Outcomes in Clinical Trials.</span></p>
<p style="top:525.1pt;left:217.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Mortality was re-</span></p>
<p style="top:537.0pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ported in all studies except Bocchi et al. Comparing therapy</span></p>
<p style="top:549.0pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and control groups, Vrtovec et al (2011) found a signi&#xfb01;-</span></p>
<p style="top:561.0pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cantly lower incidence of heart transplantation or mortality</span></p>
<p style="top:572.9pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">in the therapy group (7% vs 30%;</span><span style="font-family:AdvPSA88C,serif;font-size:10.0pt"> P</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt"> 5</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> .03). At 5-year</span></p>
<p style="top:584.8pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">follow-up, Vrtovec et al (2013) found a lower total mortal-</span></p>
<p style="top:596.8pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ity in patients receiving stem cell therapy compared with</span></p>
<p style="top:608.8pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">control subjects (14% vs 35%;</span><span style="font-family:AdvPSA88C,serif;font-size:10.0pt"> P</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt"> 5</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> .01); occurrence of</span></p>
<p style="top:620.7pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">heart transplantation did not differ between the 2 groups.</span></p>
<p style="top:632.7pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">The other controlled studies found similar mortality rates.</span></p>
<p style="top:644.7pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Chin et al, Fatkhutdinov et al, and Schannwell et al found</span></p>
<p style="top:656.6pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">no mortality in both groups, and of the 85 patients included</span></p>
<p style="top:668.5pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">by Seth et al 12 treated patients vs 14 control subjects had</span></p>
<p style="top:680.5pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">died after 3 years of follow-up. In the study by Arg</span><span style="font-family:AdvP4C4E59,serif;font-size:10.0pt">&#x20ac;</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">uero</span></p>
<p style="top:692.5pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al, which mainly included patients with ischemic cardio-</span></p>
<p style="top:704.4pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">myopathy, 2 patients died because of intractable arrhyth-</span></p>
<p style="top:716.4pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">mias, but there was no information given of which group</span></p>
<p style="top:728.3pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">either of these patients belonged to. Benetti et al, Kalil</span></p>
<p style="top:501.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al, and Martino et al reported some cases with de novo</span></p>
<p style="top:513.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">(supra)ventricular arrhythmias, quickly terminated with</span></p>
<p style="top:525.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">chemical or electrical cardioversion. The other studies did</span></p>
<p style="top:537.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">not show an increase in arrhythmias (only Seth et al gave</span></p>
<p style="top:549.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">no information on occurrence of arrhythmias).</span></p>
<p style="top:583.9pt;left:403.8pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Discussion</span></p>
<p style="top:608.8pt;left:320.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">In total, 29 preclinical and 15 clinical studies were in-</span></p>
<p style="top:620.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cluded in this systematic review on cell therapy for</span></p>
<p style="top:632.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">DCM. Main &#xfb01;ndings were: 1) a low methodologic quality</span></p>
<p style="top:644.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">in general; 2) a large heterogeneity in inclusion criteria,</span></p>
<p style="top:656.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">procedural characteristics, and outcome measures; 3) only</span></p>
<p style="top:668.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">2 preclinical studies involving large animals; 4) a signi&#xfb01;cant</span></p>
<p style="top:680.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">increase in LVEF, improvement in NYHA functional class,</span></p>
<p style="top:692.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and QoL at follow-up after cell therapy in the majority of</span></p>
<p style="top:704.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">clinical studies (from a total of 513 enrolled patients); 5)</span></p>
<p style="top:716.4pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">several reports of potentially life-threatening arrhythmias;</span></p>
<p style="top:728.4pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and 6) no increased mortality after cell therapy.</span></p>
<p style="top:58.8pt;left:194.7pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Table 1.</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Preclinical Study Characteristics and Outcomes</span></p>
<p style="top:86.6pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Author</span></p>
<p style="top:86.6pt;left:126.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Model</span></p>
<p style="top:76.7pt;left:159.7pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">n (Total/Cell</span></p>
<p style="top:86.6pt;left:167.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Treated)</span></p>
<p style="top:86.6pt;left:215.5pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Randomized</span></p>
<p style="top:76.7pt;left:270.3pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Follow-Up</span></p>
<p style="top:86.6pt;left:281.4pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">(wk)</span></p>
<p style="top:76.7pt;left:328.0pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Cell</span></p>
<p style="top:86.6pt;left:326.6pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Type</span></p>
<p style="top:86.6pt;left:361.6pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Outcome</span></p>
<p style="top:76.7pt;left:403.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Measuring</span></p>
<p style="top:86.6pt;left:409.2pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Method</span></p>
<p style="top:76.7pt;left:457.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Measured</span></p>
<p style="top:86.6pt;left:463.9pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Effect</span></p>
<p style="top:86.6pt;left:514.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88C,serif;font-size:9.0pt">P</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Value</span></p>
<p style="top:105.3pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Large animals</span></p>
<p style="top:114.2pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Hata (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">29</span></sup></p>
<p style="top:114.2pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:114.2pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12/5</span></p>
<p style="top:114.2pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:114.2pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:114.2pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:114.2pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:114.2pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:114.2pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6.5%</span></p>
<p style="top:114.2pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:123.2pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Psaltis (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">30</span></sup></p>
<p style="top:123.2pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:123.2pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15/7</span></p>
<p style="top:123.2pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:123.2pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8</span></p>
<p style="top:123.2pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MPC</span></p>
<p style="top:123.2pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">*</span></p>
<p style="top:123.2pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:123.2pt;left:464.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">10%</span></p>
<p style="top:123.2pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:132.2pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Small animals</span></p>
<p style="top:141.1pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Baba (2007)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">11</span></sup></p>
<p style="top:141.1pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:141.1pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">67/20</span></p>
<p style="top:141.1pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:141.1pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:141.1pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ES</span></p>
<p style="top:141.1pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">dP/dt</span></p>
<p style="top:141.1pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:141.1pt;left:451.7pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">27%/</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">20%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:141.1pt;left:507.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">&#x2018;&#x2018;signi&#xfb01;cant&#x2019;&#x2019;</span></p>
<p style="top:150.1pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Chen (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">13</span></sup></p>
<p style="top:150.1pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:150.1pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">24/8</span></p>
<p style="top:150.1pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:150.1pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:150.1pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:150.1pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:150.1pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:150.1pt;left:461.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">11.1%</span></p>
<p style="top:150.1pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:159.1pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Chen (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">41</span></sup></p>
<p style="top:159.1pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:159.1pt;left:179.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">19/6</span></p>
<p style="top:159.1pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:159.1pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:159.1pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BM-MSC</span></p>
<p style="top:159.1pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:159.1pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:159.1pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6.4%</span></p>
<p style="top:159.1pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:168.0pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">de Angelis (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">8</span></sup></p>
<p style="top:168.0pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:168.0pt;left:172.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">160/?</span></p>
<p style="top:168.0pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:168.0pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6</span></p>
<p style="top:168.0pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CPC</span></p>
<p style="top:168.0pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:168.0pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:168.0pt;left:459.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">24%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:168.0pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:177.0pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Dhein (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">7</span></sup></p>
<p style="top:177.0pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:177.0pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">38/14</span></p>
<p style="top:177.0pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:177.0pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:177.0pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BM-MSC</span></p>
<p style="top:177.0pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">dP/dt</span></p>
<p style="top:177.0pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:177.0pt;left:451.7pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">62%/</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">88%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:177.0pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:185.9pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Garbade (2009)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">42</span></sup></p>
<p style="top:185.9pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:185.9pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">31/15</span></p>
<p style="top:185.9pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:185.9pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:185.9pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:185.9pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:185.9pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:185.9pt;left:466.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3%</span></p>
<p style="top:185.9pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.01</span></p>
<p style="top:194.9pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Ishida (2004)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">43</span></sup></p>
<p style="top:194.9pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:194.9pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">52/18</span></p>
<p style="top:194.9pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:194.9pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:194.9pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:194.9pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:194.9pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:194.9pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4.1%</span></p>
<p style="top:194.9pt;left:525.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:203.9pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Jin (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">6</span></sup></p>
<p style="top:203.9pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:203.9pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">20/10</span></p>
<p style="top:203.9pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:203.9pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:203.9pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:203.9pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">dP/dt</span></p>
<p style="top:203.9pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:203.9pt;left:451.7pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">35%/</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">32%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:203.9pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:212.9pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Kondoh (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">9</span></sup></p>
<p style="top:212.9pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5</span></p>
<p style="top:212.9pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">85/57</span></p>
<p style="top:212.9pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:212.9pt;left:285.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:212.9pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:212.9pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:212.9pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:212.9pt;left:461.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:212.9pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:221.8pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Kondoh (2007)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">44</span></sup></p>
<p style="top:221.8pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5</span></p>
<p style="top:221.8pt;left:171.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">100/24</span></p>
<p style="top:221.8pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:221.8pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8</span></p>
<p style="top:221.8pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:221.8pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:221.8pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:221.8pt;left:464.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">31%</span></p>
<p style="top:221.8pt;left:525.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:230.8pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Lin (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">45</span></sup></p>
<p style="top:230.8pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1</span></p>
<p style="top:230.8pt;left:179.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">40/8</span></p>
<p style="top:230.8pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:230.8pt;left:285.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">13</span></p>
<p style="top:230.8pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ADMSC</span></p>
<p style="top:230.8pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:230.8pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:230.8pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4.1%</span></p>
<p style="top:230.8pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.0001</span></p>
<p style="top:239.7pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Lu (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">46</span></sup></p>
<p style="top:239.7pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:239.7pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">35/18</span></p>
<p style="top:239.7pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:239.7pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:239.7pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:239.7pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:239.7pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:239.7pt;left:469.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">11%</span></p>
<p style="top:239.7pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:248.7pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Mu (2011)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">47</span></sup></p>
<p style="top:248.7pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:248.7pt;left:171.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">120/40</span></p>
<p style="top:248.7pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:248.7pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:248.7pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BM-MSC</span></p>
<p style="top:248.7pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">dP/dt</span></p>
<p style="top:248.7pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:248.7pt;left:451.7pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">32%/</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">18%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:248.7pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:257.7pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Nagaya (2005)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">48</span></sup></p>
<p style="top:257.7pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1</span></p>
<p style="top:257.7pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">30/10</span></p>
<p style="top:257.7pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:257.7pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:257.7pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MSC</span></p>
<p style="top:257.7pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:257.7pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:257.7pt;left:459.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">11%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:257.7pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:266.7pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Nakajima (2008)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">49</span></sup></p>
<p style="top:266.7pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:266.7pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">25/16</span></p>
<p style="top:266.7pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:266.7pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:266.7pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:266.7pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:266.7pt;left:411.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BF, abs</span></p>
<p style="top:266.7pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3.1%</span></p>
<p style="top:266.7pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:275.6pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Nomura (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">50</span></sup></p>
<p style="top:275.6pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:275.6pt;left:180.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">?/15</span></p>
<p style="top:275.6pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:275.6pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:275.6pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MDPC</span></p>
<p style="top:275.6pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:275.6pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:275.6pt;left:461.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:275.6pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:284.6pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Ohno (2002)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">51</span></sup></p>
<p style="top:284.6pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:284.6pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">41/11</span></p>
<p style="top:284.6pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:284.6pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5</span></p>
<p style="top:284.6pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:284.6pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">PSP</span></p>
<p style="top:284.6pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:284.6pt;left:457.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">68%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">y</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt">,</span></sup><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:284.6pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.001</span></p>
<p style="top:293.5pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Pouly (2004)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">52</span></sup></p>
<p style="top:293.5pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:293.5pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">26/14</span></p>
<p style="top:293.5pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:293.5pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:293.5pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:293.5pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FAC</span></p>
<p style="top:293.5pt;left:412.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BF, rel</span></p>
<p style="top:293.5pt;left:464.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">24%</span></p>
<p style="top:293.5pt;left:523.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.019</span></p>
<p style="top:302.5pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Shabbir (2009)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">53</span></sup></p>
<p style="top:302.5pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:302.5pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">33/15</span></p>
<p style="top:302.5pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:302.5pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:302.5pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MSC</span></p>
<p style="top:302.5pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:302.5pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:302.5pt;left:459.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">13%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:302.5pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.001</span></p>
<p style="top:311.5pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Singla (2012)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">54</span></sup></p>
<p style="top:311.5pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:311.5pt;left:180.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">?/?</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">z</span></sup></p>
<p style="top:311.5pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:311.5pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:311.5pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CM or ES</span></p>
<p style="top:311.5pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:311.5pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:311.5pt;left:466.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5%</span></p>
<p style="top:311.5pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:320.5pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Sun (2009)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">55</span></sup></p>
<p style="top:320.5pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1</span></p>
<p style="top:320.5pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">28/10</span></p>
<p style="top:320.5pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:320.5pt;left:285.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">13</span></p>
<p style="top:320.5pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:320.5pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:320.5pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:320.5pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5.5%</span></p>
<p style="top:320.5pt;left:523.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.0002</span></p>
<p style="top:329.4pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Suzuki (2001)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">56</span></sup></p>
<p style="top:329.4pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:329.4pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">16/8</span></p>
<p style="top:329.4pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:329.4pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:329.4pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:329.4pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">dP/dt</span></p>
<p style="top:329.4pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:329.4pt;left:451.7pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">20%/</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">20%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:329.4pt;left:523.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.01</span></p>
<p style="top:338.4pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Tezuka (2008)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">12</span></sup></p>
<p style="top:338.4pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:338.4pt;left:180.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">?/?</span></p>
<p style="top:338.4pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:338.4pt;left:285.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15</span></p>
<p style="top:338.4pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MB</span></p>
<p style="top:338.4pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">dP/dt</span></p>
<p style="top:338.4pt;left:411.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, rel</span></p>
<p style="top:338.4pt;left:451.7pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15%/</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">37%</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:338.4pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:347.3pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Werner (2005)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">57</span></sup></p>
<p style="top:347.3pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1</span></p>
<p style="top:347.3pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">25/12</span></p>
<p style="top:347.3pt;left:233.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">No</span></p>
<p style="top:347.3pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:347.3pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EPC</span></p>
<p style="top:347.3pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:347.3pt;left:412.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BF, rel</span></p>
<p style="top:347.3pt;left:464.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15%</span></p>
<p style="top:347.3pt;left:513.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Unknown</span></p>
<p style="top:356.3pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yamada (2008)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">10</span></sup></p>
<p style="top:356.3pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6</span></p>
<p style="top:356.3pt;left:171.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">118/8</span></p>
<p style="top:356.3pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:356.3pt;left:285.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">21</span></p>
<p style="top:356.3pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ES</span></p>
<p style="top:356.3pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:356.3pt;left:411.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BF, abs</span></p>
<p style="top:356.3pt;left:461.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12.5%</span></p>
<p style="top:356.3pt;left:515.7pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:365.3pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Zhang (2005)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">58</span></sup></p>
<p style="top:365.3pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:365.3pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">42/18</span></p>
<p style="top:365.3pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:365.3pt;left:289.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4</span></p>
<p style="top:365.3pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:365.3pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">FS</span></p>
<p style="top:365.3pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:365.3pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3.8%</span></p>
<p style="top:365.3pt;left:525.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:374.3pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Zhou (2007)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">59</span></sup></p>
<p style="top:374.3pt;left:136.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:374.3pt;left:175.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">20/10</span></p>
<p style="top:374.3pt;left:232.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Yes</span></p>
<p style="top:374.3pt;left:285.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:374.3pt;left:318.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:374.3pt;left:369.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">EF</span></p>
<p style="top:374.3pt;left:410.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CT, abs</span></p>
<p style="top:374.3pt;left:463.5pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">0.1%</span></p>
<p style="top:374.3pt;left:525.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:392.1pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Disease model: 1) porcine myosin</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt"> Freund adjuvant; 2) genetic</span><span style="font-family:AdvPS3F4C13,serif;font-size:8.0pt"> d</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">-sarcoglycan de&#xfb01;ciency; 3) doxorubicin or adriamycin; 4) pacing-induced DCM (230/</span></p>
<p style="top:401.0pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">min); 5) BIO TO-2 hamsters; 6) Kir 6.2 knockout</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt"> &#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt"> aortic constriction. Cell type: ADMSC, adipose-derived stem cells; BM(M)C, bone marrow (mononu-</span></p>
<p style="top:410.0pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">clear) cells; CM, conditioned medium; CPC, cardiac progenitor cells; EPC, endothelial progenitor cells; ES, embryonic stem cells; MB, myoblasts; MDPC,</span></p>
<p style="top:419.0pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">myosphere-derived progenitor cell; MPC, mesenchymal precursor cells; MSC, mesenchymal stem cells. Measuring method: BF, baseline vs follow-up; CT,</span></p>
<p style="top:427.9pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">control vs therapy; abs, absolute difference; rel, relative difference. EF, ejection fraction; dP/dt, delta pressure/delta time; FS, fractional shortening; FAC,</span></p>
<p style="top:436.9pt;left:47.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">fractional area change; PSP, peak systolic pressure; ns, nonsigni&#xfb01;cant.</span></p>
<p style="top:445.9pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">*Determined with the use of MRI.</span></p>
<p style="top:453.2pt;left:55.8pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">y</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Average difference in PSP.</span></p>
<p style="top:462.1pt;left:55.8pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">z</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Singla used 6</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8 animals per group; 1 group underwent cell therapy.</span></p>
<p style="top:471.1pt;left:55.8pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">x</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Measured effect of dP/dt (maximum/minimum).</span></p>
<p style="top:480.0pt;left:55.8pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">k</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Estimated effect based on graphics.</span></p>
<p style="top:34.9pt;left:298.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Cell Therapy for Dilated Cardiomyopathy</span><span style="font-family:AdvP4C4E74,serif;font-size:13.0pt"> &#xfffd;</span></p>
<p style="top:34.9pt;left:486.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Gho et al</span></p>
<p style="top:34.2pt;left:533.4pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">497</span></p>


<p style="top:294.1pt;left:44.1pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">From &#x2018;&#x2018;Bench to Bedside&#x2019;&#x2019;</span></p>
<p style="top:312.2pt;left:54.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Study validity in preclinical studies showed a lack in</span></p>
<p style="top:324.2pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">methodologic quality, about one-half were randomized,</span></p>
<p style="top:336.2pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and only 1 study used concealed allocation. No blinding</span></p>
<p style="top:348.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">was performed in the majority of the included articles.</span></p>
<p style="top:360.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">We found a large heterogeneity among studies in disease</span></p>
<p style="top:372.0pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">models, therapy, and end points. It is therefore dif&#xfb01;cult to</span></p>
<p style="top:294.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">combine the results to infer a stronger conclusion on stem</span></p>
<p style="top:306.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cell therapy. However, all studies showed a positive effect</span></p>
<p style="top:317.9pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">on left ventricular function, mostly by attenuation of dete-</span></p>
<p style="top:329.9pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">rioration, also shown in the studies reporting interim results</span></p>
<p style="top:341.9pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">(</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Fig. 3</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). Largest improvement was found by de Angelis</span></p>
<p style="top:353.8pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">et al using cardiac progenitor cells on doxorubicin-</span></p>
<p style="top:365.7pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">induced cardiomyopathy in rats. Contractility also was</span></p>
<img style="position:absolute;transform:matrix(.31997327,0,-0,.3198705,-303.43733,-192.67197)" src="data:image/jpeg;base64,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=">
<p style="top:261.8pt;left:152.5pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Fig. 2.</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Flowchart of search strategy clinical trials. Abbreviations as in</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt;color:#000066"> Fig. 1</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">.</span></p>
<p style="top:397.6pt;left:196.0pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Table 2.</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Clinical Study Characteristics and Outcomes</span></p>
<p style="top:415.4pt;left:44.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Author (year)</span></p>
<p style="top:415.4pt;left:135.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Group</span></p>
<p style="top:415.4pt;left:169.3pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">n (total)</span></p>
<p style="top:415.4pt;left:208.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Follow-Up (mo)</span></p>
<p style="top:415.4pt;left:276.4pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Delivery Route</span></p>
<p style="top:415.4pt;left:355.4pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Cell Type</span></p>
<p style="top:415.4pt;left:414.6pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">EF Mean Difference (%)</span></p>
<p style="top:415.4pt;left:516.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88C,serif;font-size:9.0pt">P</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Value</span></p>
<p style="top:434.1pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCTs</span></p>
<p style="top:443.0pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Bocchi (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">27</span></sup></p>
<p style="top:443.0pt;left:133.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Therapy</span></p>
<p style="top:443.0pt;left:170.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">14 (23)</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">*</span></p>
<p style="top:443.0pt;left:228.8pt;line-height:8.0pt"><span style="font-family:AdvPS7DA6,serif;font-size:8.0pt">6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt;color:#000066">y</span></p>
<p style="top:443.0pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:443.0pt;left:340.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC</span></p>
<p style="top:443.0pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8.8</span></p>
<p style="top:443.0pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.016</span></p>
<p style="top:452.0pt;left:133.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Control</span></p>
<p style="top:452.0pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8</span></p>
<p style="top:452.0pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5.6</span></p>
<p style="top:452.0pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.04</span></p>
<p style="top:460.9pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Seth (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">21</span></sup></p>
<p style="top:460.9pt;left:133.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Therapy</span></p>
<p style="top:460.9pt;left:172.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">44 (85)</span></p>
<p style="top:460.9pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">36</span></p>
<p style="top:460.9pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:460.9pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC</span></p>
<p style="top:460.9pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5.9</span></p>
<p style="top:460.9pt;left:517.8pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.05</span></p>
<p style="top:470.0pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Control</span></p>
<p style="top:470.0pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">41</span></p>
<p style="top:470.0pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">0.4</span></p>
<p style="top:470.0pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:478.9pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Vrtovec (2011)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">22</span></sup></p>
<p style="top:478.9pt;left:133.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Therapy</span></p>
<p style="top:478.9pt;left:170.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">28 (61)</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">z</span></sup></p>
<p style="top:478.9pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:478.9pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:478.9pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Autologous CD34</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span></p>
<p style="top:478.9pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4.6</span></p>
<p style="top:478.9pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.03</span></p>
<p style="top:487.9pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Control</span></p>
<p style="top:487.9pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">27</span></p>
<p style="top:487.9pt;left:447.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:487.9pt;left:515.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Unknown</span></p>
<p style="top:496.8pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Vrtovec (2013)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">15</span></sup></p>
<p style="top:496.8pt;left:133.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Therapy</span></p>
<p style="top:496.8pt;left:168.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">55 (131)</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">z</span></sup></p>
<p style="top:496.8pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">60</span></p>
<p style="top:496.8pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:496.8pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Autologous CD34</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span></p>
<p style="top:496.8pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5.7</span></p>
<p style="top:496.8pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.02</span></p>
<p style="top:505.8pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Control</span></p>
<p style="top:505.8pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">55</span></p>
<p style="top:505.8pt;left:447.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:505.8pt;left:515.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Unknown</span></p>
<p style="top:514.7pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Non-RCTs</span></p>
<p style="top:523.8pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Fatkhutdinov (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">17</span></sup></p>
<p style="top:523.8pt;left:133.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Therapy</span></p>
<p style="top:523.8pt;left:174.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6 (14)</span></p>
<p style="top:523.8pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:523.8pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:523.8pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Allogenic MSC</span></p>
<p style="top:523.8pt;left:453.1pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">0</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:523.8pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:532.7pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Control</span></p>
<p style="top:532.7pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8</span></p>
<p style="top:532.7pt;left:447.0pt;line-height:8.0pt"><span style="font-family:AdvPS3FDD77,serif;font-size:8.0pt">w</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">k</span></sup></p>
<p style="top:532.7pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:541.7pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Schannwell (2008)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">18</span></sup></p>
<p style="top:541.7pt;left:133.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Therapy</span></p>
<p style="top:541.7pt;left:172.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">10 (20)</span></p>
<p style="top:541.7pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:541.7pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:541.7pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC-MN</span></p>
<p style="top:541.7pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">9</span></p>
<p style="top:541.7pt;left:517.8pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.01</span></p>
<p style="top:550.6pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Control</span></p>
<p style="top:550.6pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">10</span></p>
<p style="top:550.6pt;left:464.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">0</span></p>
<p style="top:550.6pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:559.6pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Cohort</span></p>
<p style="top:568.5pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Arg</span><span style="font-family:AdvP4C4E59,serif;font-size:8.0pt">&#x20ac;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">uero (2006)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">23</span></sup></p>
<p style="top:568.5pt;left:174.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3 (5)</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">x</span></sup></p>
<p style="top:568.5pt;left:222.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Unknown</span></p>
<p style="top:568.5pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Surgical</span></p>
<p style="top:568.5pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Autologous CD34</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span></p>
<p style="top:568.5pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8.7</span></p>
<p style="top:568.5pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.0059</span></p>
<p style="top:577.5pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Benetti (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">19</span></sup></p>
<p style="top:577.5pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">10</span></p>
<p style="top:577.5pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">40</span></p>
<p style="top:577.5pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Surgical</span></p>
<p style="top:577.5pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">HFDSC</span></p>
<p style="top:577.5pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8.2</span></p>
<p style="top:577.5pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.005</span></p>
<p style="top:586.5pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Chin (2011)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">24</span></sup></p>
<p style="top:586.5pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3</span></p>
<p style="top:586.5pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:586.5pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:586.5pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BM-MSC</span></p>
<p style="top:586.5pt;left:453.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15.1</span></p>
<p style="top:586.5pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:595.5pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Fischer-Rasokat (2009)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">26</span></sup></p>
<p style="top:595.5pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">33</span></p>
<p style="top:595.5pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:595.5pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:595.5pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC</span></p>
<p style="top:595.5pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3.2</span></p>
<p style="top:595.5pt;left:517.8pt;line-height:8.0pt"><span style="font-family:AdvPS4731B1,serif;font-size:8.0pt">!</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.001</span></p>
<p style="top:604.4pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Kalil (2008)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">28</span></sup></p>
<p style="top:604.4pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">9</span></p>
<p style="top:604.4pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:604.4pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Surgical</span></p>
<p style="top:604.4pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC</span></p>
<p style="top:604.4pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">0.5</span></p>
<p style="top:604.4pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.023</span></p>
<p style="top:613.4pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Kirillov (2007)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">25</span></sup></p>
<p style="top:613.4pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Group 1</span></p>
<p style="top:613.4pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">9</span></p>
<p style="top:613.4pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6</span></p>
<p style="top:613.4pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:613.4pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Prenatal ASM</span></p>
<p style="top:613.4pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2</span></p>
<p style="top:613.4pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:622.3pt;left:133.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Group 2</span></p>
<p style="top:622.3pt;left:184.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">7</span></p>
<p style="top:622.3pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Prenatal MSC</span></p>
<p style="top:622.3pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1.6</span></p>
<p style="top:622.3pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:631.3pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Martino (2010)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">20</span></sup></p>
<p style="top:631.3pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">24</span></p>
<p style="top:631.3pt;left:242.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6</span></p>
<p style="top:631.3pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:631.3pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC-MN</span></p>
<p style="top:631.3pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1.2</span></p>
<p style="top:631.3pt;left:527.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ns</span></p>
<p style="top:640.3pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Ruengsakulrach (2011)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">14</span></sup></p>
<p style="top:640.3pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">52</span></p>
<p style="top:640.3pt;left:229.7pt;line-height:8.0pt"><span style="font-family:AdvPS7DA6,serif;font-size:8.0pt">6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">13</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">y</span></sup></p>
<p style="top:640.3pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Surgical</span></p>
<p style="top:640.3pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ACP</span></p>
<p style="top:640.3pt;left:457.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4.4</span></p>
<p style="top:640.3pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.03</span></p>
<p style="top:649.3pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Su</span><span style="font-family:AdvP4C4E59,serif;font-size:8.0pt">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">arez de Lezo (2013)</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">16</span></sup></p>
<p style="top:649.3pt;left:180.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">27</span></p>
<p style="top:649.3pt;left:238.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12</span></p>
<p style="top:649.3pt;left:291.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:649.3pt;left:341.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMMC</span></p>
<p style="top:649.3pt;left:453.9pt;line-height:8.0pt"><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">11</span></p>
<p style="top:649.3pt;left:525.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.001</span></p>
<p style="top:667.1pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT, randomized controlled trial; Cohort, cohort study. Cell type: ACP, angiogenic cell precursors; ASM, allogenic skeletal myoblasts; BM(M)C, bone</span></p>
<p style="top:676.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">marrow (mononuclear) cells; HFDSC, human fetal-derived stem cells; MSC, mesenchymal stem cell; MN, mononuclear; EF, ejection fraction; G-CSF, gran-</span></p>
<p style="top:685.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ulocyte colony</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">stimulating factor; IC, intracoronary; ns, nonsigni&#xfb01;cant.</span></p>
<p style="top:694.0pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">*Randomized to G-CSF administration (14) or G-CSF associated to BMSC intracoronary infusion (8).</span></p>
<p style="top:701.3pt;left:52.1pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">y</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Bocchi et al mean 468</span><span style="font-family:AdvPS7DA6,serif;font-size:8.0pt"> 6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt"> 374 days (up to 1,190 days), Ruengsakulrach et al mean 409.7</span><span style="font-family:AdvPS7DA6,serif;font-size:8.0pt"> 6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt"> 352.4 days.</span></p>
<p style="top:710.3pt;left:52.1pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">z</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">All patients received G-CSF before randomization; 6 (2011) and 21 (2013) patients were excluded in this phase.</span></p>
<p style="top:719.2pt;left:52.1pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">x</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3/5 patients included in preliminary report, outcomes calculated.</span></p>
<p style="top:728.2pt;left:52.1pt;line-height:5.6pt"><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt">k</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Estimated difference based on graphics.</span></p>
<p style="top:34.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">498</span></p>
<p style="top:35.7pt;left:70.1pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Journal of Cardiac Failure Vol. 19 No. 7 July 2013</span></p>


<p style="top:181.3pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">signi&#xfb01;cantly and positively in&#xfb02;uenced. Comparing stem</span></p>
<p style="top:193.2pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cell</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">treated animals with control animals, 10 out of 29</span></p>
<p style="top:205.2pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studies reported equal mortality or sometimes even im-</span></p>
<p style="top:217.2pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">provement of survival. No conclusion can be drawn regard-</span></p>
<p style="top:229.1pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ing arrhythmias, which was reported in only 4 studies.</span></p>
<p style="top:241.0pt;left:57.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Main proposed mechanisms of stem cell effects on DCM</span></p>
<p style="top:253.0pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">include reduction of &#xfb01;brosis and angiogenesis by direct (cell</span></p>
<p style="top:265.0pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">engraftment, regenerative transdifferentiation) and paracrine</span></p>
<p style="top:276.9pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">support.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">29,30</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">No additional &#xfb01;brosis is seen following therapy;</span></p>
<p style="top:288.9pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sometimes even attenuation is seen. It remains possible that</span></p>
<p style="top:300.8pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">publication bias and methods of measurement attributed an</span></p>
<p style="top:312.8pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">overestimation and positive image of stem cell therapy for</span></p>
<p style="top:324.8pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">DCM. Left ventricular hemodynamics and MRI are more ob-</span></p>
<p style="top:336.7pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">jective than 2-dimensional echocardiography in measuring</span></p>
<p style="top:348.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">left ventricular function. An optimal animal model for DCM</span></p>
<p style="top:360.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">is still lacking. Overall, stem cell therapy seems to be feasible</span></p>
<p style="top:372.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and effective in preclinical models; however, large animal</span></p>
<p style="top:384.5pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">studies are scarce in the transition from bench to bedside.</span></p>
<p style="top:411.3pt;left:47.8pt;line-height:9.0pt"><span style="font-family:AdvPSHEL,serif;font-size:9.0pt">Back from &#x2018;&#x2018;Bedside to Bench&#x2019;&#x2019;</span></p>
<p style="top:429.4pt;left:59.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Quality Assessment, Safety, and Ef&#xfb01;cacy in Clinical</span></p>
<p style="top:441.4pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Trials.</span></p>
<p style="top:441.4pt;left:85.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">In 2006 consensus of the Task Force of the Euro-</span></p>
<p style="top:453.3pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">pean Society of Cardiology (ESC) addressed the possible</span></p>
<p style="top:465.3pt;left:47.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">need for autologous cell therapy in DCM.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">31</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">In the same</span></p>
<p style="top:477.2pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">year, the &#xfb01;rst human clinical trials were reported, and in</span></p>
<p style="top:489.2pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">summary they were predominantly pioneering trials assess-</span></p>
<p style="top:501.1pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ing safety and ef&#xfb01;cacy. There was a lack in methodologic</span></p>
<p style="top:513.1pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">quality, because mainly nonrandomized trials were per-</span></p>
<p style="top:525.1pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">formed. Lack of allocation concealment, placebo effect,</span></p>
<p style="top:537.0pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">or procedural characteristics, such as delivery techniques</span></p>
<p style="top:549.0pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and growth factor administration, could have in&#xfb02;uenced</span></p>
<p style="top:561.0pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">the outcome. Especially studies with a short follow-up</span></p>
<p style="top:572.9pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">period should be interpreted with caution regarding whether</span></p>
<p style="top:584.8pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">the positive outcome would be sustained over a longer pe-</span></p>
<p style="top:596.8pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">riod. We noticed a large heterogeneity in inclusion criteria,</span></p>
<p style="top:608.8pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">procedural characteristics, and outcome measures.</span></p>
<p style="top:620.7pt;left:57.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">These studies showed no increase in mortality in the cell</span></p>
<p style="top:632.7pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">therapy groups. There were several reports on potentially</span></p>
<p style="top:644.7pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">life-threatening arrhythmias.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">19,20,23,28</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Furthermore, a case re-</span></p>
<p style="top:656.6pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">port (n</span><span style="font-family:AdvPS7DA6,serif;font-size:10.0pt"> 5</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> 2) describing a pilot trial on cell therapy in DCM</span></p>
<p style="top:668.5pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">showed severe complications after intracoronary balloon in-</span></p>
<p style="top:680.5pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">&#xfb02;ation, with hypotension and ventricular arrhythmias in one</span></p>
<p style="top:692.4pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">patient and severe spasm with hypotension requiring bailout</span></p>
<p style="top:704.4pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">stenting in another; therefore, that trial was prematurely ter-</span></p>
<p style="top:716.4pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">minated.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">32</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">So these procedures carry an arrhythmic risk,</span></p>
<p style="top:728.3pt;left:47.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">which should be assessed in future studies.</span></p>
<p style="top:181.3pt;left:320.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">There seems to be a positive effect of cell therapy for</span></p>
<p style="top:193.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">DCM on LVEF, NYHA functional class and QoL, although</span></p>
<p style="top:205.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">this should be veri&#xfb01;ed in large randomized trials. Also,</span></p>
<p style="top:217.2pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">more studies are needed for determining optimal delivery</span></p>
<p style="top:229.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">route and cell type for cardiac repair. Outcomes should</span></p>
<p style="top:241.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">be given as absolute differences to more accurately estimate</span></p>
<p style="top:253.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">actual treatment effect. This would result in clear indica-</span></p>
<p style="top:265.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">tions for cell therapy in nonischemic cardiomyopathy, pref-</span></p>
<p style="top:276.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">erable above random patient selection. Using multiple</span></p>
<p style="top:288.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">&#x2018;&#x2018;rising&#x2019;&#x2019; imaging modalities, such as MRI, 3-dimensional</span></p>
<p style="top:300.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">echocardiography, and single-photon emission computed</span></p>
<p style="top:312.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">tomography, would provide more accuracy for determining</span></p>
<p style="top:324.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">outcomes.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">33</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Although we would prefer MRI to determine</span></p>
<p style="top:336.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">outcome measures, certain heart failure patients would be</span></p>
<p style="top:348.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ineligible because of implanted devices, such as implant-</span></p>
<p style="top:360.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">able cardioverter-de&#xfb01;brillator and cardiac resynchroniza-</span></p>
<p style="top:372.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">tion</span></p>
<p style="top:372.6pt;left:339.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">therapy.</span></p>
<p style="top:372.6pt;left:385.2pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Besides</span></p>
<p style="top:372.6pt;left:429.7pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">clinically</span></p>
<p style="top:372.6pt;left:480.6pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">relevant</span></p>
<p style="top:372.6pt;left:525.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">LVEF</span></p>
<p style="top:384.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">measurements, detailed measuring of local cardiac function</span></p>
<p style="top:396.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">can provide information about local changes induced by</span></p>
<p style="top:408.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cardiac</span></p>
<p style="top:408.5pt;left:347.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">regenerative</span></p>
<p style="top:408.5pt;left:405.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">therapy.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">34</span></sup></p>
<p style="top:408.4pt;left:452.6pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Combined</span></p>
<p style="top:408.4pt;left:502.4pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">global</span></p>
<p style="top:408.4pt;left:535.5pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and</span></p>
<p style="top:420.4pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">regional myocardial function measurements are recommen-</span></p>
<p style="top:432.3pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ded to assess the effects of cardiac regenerative therapy.</span></p>
<p style="top:444.3pt;left:322.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88B,serif;font-size:10.0pt">Elucidating Underlying Mechanisms.</span></p>
<p style="top:444.3pt;left:499.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Current evi-</span></p>
<p style="top:456.2pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">dence reveals controversy regarding stem cell transdifferen-</span></p>
<p style="top:468.2pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">tiation to cardiomyocytes contributing to cardiac functional</span></p>
<p style="top:480.2pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">gain, which has led to investigating paracrine mechanisms</span></p>
<p style="top:492.1pt;left:310.9pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">for repair.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">35,36</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">In contrast to cell therapy for ischemic cardio-</span></p>
<p style="top:504.1pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">myopathy, where angiogenesis plays an important role, in</span></p>
<p style="top:516.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">DCM heart muscle disease and myocardial dysfunction pres-</span></p>
<p style="top:528.0pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ent a different background. However, marked vascular de-</span></p>
<p style="top:539.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">rangements and impaired vasculogenic and angiogenic</span></p>
<p style="top:551.9pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">responses have also been reported in idiopathic DCM.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">37</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Pro-</span></p>
<p style="top:563.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">posed underlying working mechanisms should be differenti-</span></p>
<p style="top:575.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ated between ischemic cardiomyopathy and DCM, e.g., by</span></p>
<p style="top:587.8pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">elucidating these issues in preclinical studies. Findings from</span></p>
<p style="top:599.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">clinical studies should also be clari&#xfb01;ed in collaboration</span></p>
<p style="top:611.7pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">with preclinical research. As progress is being made for</span></p>
<p style="top:623.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">DCM in unraveling underlying genetic mutations and molec-</span></p>
<p style="top:635.6pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ular mechanisms (e.g., calcium metabolism), these could be</span></p>
<p style="top:647.5pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">used in future for tailored cell and/or gene therapy.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">38,39</span></sup></p>
<p style="top:679.5pt;left:375.4pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Ongoing Clinical Trials</span></p>
<p style="top:704.4pt;left:320.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Several clinical trials on cell therapy for DCM are under-</span></p>
<p style="top:716.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">way (</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Table 3</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). Nine trials were found on</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066"> ClinicalTrials.gov</span></p>
<p style="top:728.3pt;left:310.8pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">(</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">Supplemental Table 3</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">). All principle investigators were</span></p>
<img style="position:absolute;transform:matrix(.31996549,0,-0,.3194261,-296.42268,-49.25064)" src="data:image/jpeg;base64,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">
<p style="top:160.5pt;left:55.0pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Fig. 3.</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Preclinical studies reporting interim results on (A) fractional shortening (FS) or (B) left ventricular ejection fraction (LVEF).</span></p>
<p style="top:34.9pt;left:298.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Cell Therapy for Dilated Cardiomyopathy</span><span style="font-family:AdvP4C4E74,serif;font-size:13.0pt"> &#xfffd;</span></p>
<p style="top:34.9pt;left:486.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Gho et al</span></p>
<p style="top:34.2pt;left:533.4pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">499</span></p>


<p style="top:295.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">contacted for up-to-date trial results, which resulted in 2</span></p>
<p style="top:307.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">complete manuscripts that were added to the clinical stud-</span></p>
<p style="top:319.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">ies section. Most studies are randomized; only 1 study is</span></p>
<p style="top:331.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">double-blind and placebo controlled with another control</span></p>
<p style="top:343.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">group receiving granulocyte colony</span><span style="font-family:AdvPS44A44B,serif;font-size:10.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">stimulating factor.</span></p>
<p style="top:355.2pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Delivery routes are intracoronary, intramyocardial, or trans-</span></p>
<p style="top:367.2pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">endocardial (mainly using the NOGA XP/Myostar injection</span></p>
<p style="top:379.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">catheter system), and different cell types are used. Primary</span></p>
<p style="top:391.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">outcome measures are assessing safety or LVEF.</span></p>
<p style="top:415.3pt;left:121.4pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Study Limitations</span></p>
<p style="top:440.1pt;left:54.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">The large heterogeneity in study characteristics of in-</span></p>
<p style="top:452.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cluded reports could have in&#xfb02;uenced outcome; therefore,</span></p>
<p style="top:464.1pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">we examined reasons for heterogeneity with the use of stan-</span></p>
<p style="top:476.0pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">dardized criteria. Differences between animal DCM models</span></p>
<p style="top:487.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and human disease carry limitations when translating from</span></p>
<p style="top:499.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">bench to bedside. Publication bias can not be ruled out, be-</span></p>
<p style="top:511.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cause smaller studies are prone to publication bias. Esti-</span></p>
<p style="top:523.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">mates of effect are vulnerable to confounding by lack of</span></p>
<p style="top:535.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">randomization. Only reported outcomes were included, be-</span></p>
<p style="top:547.8pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cause we did not have access to complete individual data</span></p>
<p style="top:559.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and accordingly, mean values are provided; authors were</span></p>
<p style="top:571.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">contacted in case of missing data.</span></p>
<p style="top:595.9pt;left:117.3pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Future Implications</span></p>
<p style="top:620.7pt;left:54.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Only a few studies on cell therapy for DCM have been</span></p>
<p style="top:632.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">performed and methodologic quality in general was low.</span></p>
<p style="top:644.7pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">The majority of studies show a signi&#xfb01;cant positive effect</span></p>
<p style="top:656.6pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">on LVEF. There is a need for methodologically sound</span></p>
<p style="top:668.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">(pre)clinical studies to elucidate underlying mechanisms</span></p>
<p style="top:680.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">and to translate these into improved therapy for clinical</span></p>
<p style="top:692.5pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">practice. Clearly described uniform de&#xfb01;nitions for inclusion</span></p>
<p style="top:704.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">should be used in future studies, e.g., derived from the ESC</span></p>
<p style="top:716.4pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">classi&#xfb01;cation.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">40</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Adequately randomized (placebo) con-</span></p>
<p style="top:728.3pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">trolled trials are mandatory to validate safety and ef&#xfb01;cacy</span></p>
<p style="top:295.5pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">of cell therapy for DCM, preferably with long-term</span></p>
<p style="top:307.4pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">follow-up. These studies should focus on occurrence of ar-</span></p>
<p style="top:319.3pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">rhythmias, mortality, optimal cell delivery techniques, and</span></p>
<p style="top:331.3pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">cell type with the use of different modern image modalities.</span></p>
<p style="top:343.3pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Stem cell therapy has shown moderate but signi&#xfb01;cant ef-</span></p>
<p style="top:355.2pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">fects in clinical trials for ischemic heart disease comprising</span></p>
<p style="top:367.2pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">almost 2,000 patients.</span><sup><span style="font-family:AdvPSA88A,serif;font-size:7.0pt;color:#000066">4</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">It still remains to be determined if</span></p>
<p style="top:379.1pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">we can extrapolate these results to DCM patients. Neverthe-</span></p>
<p style="top:391.1pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">less, this exciting &#xfb01;eld of research has shown promising re-</span></p>
<p style="top:403.1pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">sults so far and warrants continuation of ongoing study</span></p>
<p style="top:415.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">programs.</span></p>
<p style="top:441.7pt;left:398.4pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Disclosures</span></p>
<p style="top:466.6pt;left:317.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">None.</span></p>
<p style="top:506.2pt;left:378.3pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">Supplementary Data</span></p>
<p style="top:525.1pt;left:317.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">Supplementary data related to this article can be found at</span></p>
<p style="top:537.0pt;left:307.1pt;line-height:10.0pt"><span style="font-family:AdvPSA88A,serif;font-size:10.0pt;color:#000066">http://dx.doi.org/10.1016/j.cardfail.2013.05.006</span><span style="font-family:AdvPSA88A,serif;font-size:10.0pt">.</span></p>
<p style="top:575.7pt;left:399.9pt;line-height:10.0pt"><span style="font-family:AdvPSHEL,serif;font-size:10.0pt">References</span></p>
<p style="top:600.4pt;left:315.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">1.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010;375:</span></p>
<p style="top:610.3pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">752</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">62</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:620.3pt;left:315.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">2.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> van der Spoel TI, Jansen of Lorkeers SJ, Agostoni P, van Belle E,</span></p>
<p style="top:630.3pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Gyongyosi M, Sluijter JP, et al. Human relevance of pre-clinical stud-</span></p>
<p style="top:640.2pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">ies in stem cell therapy: systematic review and meta-analysis of large</span></p>
<p style="top:650.2pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">animal models of ischaemic heart disease. Cardiovasc Res 2011;91:</span></p>
<p style="top:660.2pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">649</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">58</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:670.1pt;left:315.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">3.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocar-</span></p>
<p style="top:680.1pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">dial bone marrow stem cell therapy of the heart: from the methodo-</span></p>
<p style="top:690.0pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">logical origin to clinical practice. J Am Coll Cardiol 2011;58:</span></p>
<p style="top:700.0pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">1095</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">104</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:709.9pt;left:315.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">4.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Zimmet H, Porapakkham P, Porapakkham P, Sata Y, Haas SJ,</span></p>
<p style="top:719.9pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Itescu S, et al. Short- and long-term outcomes of intracoronary and</span></p>
<p style="top:729.9pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">endogenously mobilized bone marrow stem cells in the treatment</span></p>
<p style="top:58.8pt;left:150.2pt;line-height:9.0pt"><span style="font-family:AdvPSA88B,serif;font-size:9.0pt">Table 3.</span><span style="font-family:AdvPSA88A,serif;font-size:9.0pt"> Ongoing Clinical Trials on Cell Therapy for Dilated Cardiomyopathy</span></p>
<p style="top:86.6pt;left:44.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Identi&#xfb01;er</span></p>
<p style="top:96.6pt;left:44.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">(Short Name)</span></p>
<p style="top:96.6pt;left:137.1pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Design</span></p>
<p style="top:96.6pt;left:175.7pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Blinding</span></p>
<p style="top:86.6pt;left:220.4pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Delivery</span></p>
<p style="top:96.6pt;left:225.2pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Route</span></p>
<p style="top:96.6pt;left:290.4pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Cell Type</span></p>
<p style="top:86.6pt;left:374.7pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Primary Outcome</span></p>
<p style="top:96.6pt;left:371.3pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Measure (modality)</span></p>
<p style="top:76.7pt;left:460.2pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Estimated</span></p>
<p style="top:86.6pt;left:457.0pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Completion</span></p>
<p style="top:96.6pt;left:469.8pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Date</span></p>
<p style="top:96.6pt;left:515.7pt;line-height:9.0pt"><span style="font-family:AdvPSA88A,serif;font-size:9.0pt">Status</span></p>
<p style="top:115.2pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT01302171</span></p>
<p style="top:124.2pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">(REGENERATE-DCM)</span></p>
<p style="top:115.2pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:115.2pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Double-blind</span></p>
<p style="top:115.2pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:115.2pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BM-MNC vs placebo/G-CSF</span></p>
<p style="top:115.2pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">LVEF (MRI)</span></p>
<p style="top:115.2pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Dec 2012</span></p>
<p style="top:115.2pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Recruiting</span></p>
<p style="top:133.1pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT01350310</span></p>
<p style="top:142.1pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">(NOGA-DCM)</span></p>
<p style="top:133.1pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:133.1pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Single-blind</span></p>
<p style="top:133.1pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC vs IM</span></p>
<p style="top:133.1pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CD34</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt">&#xfe;</span></p>
<p style="top:133.1pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">LVEF (echocardiography)</span></p>
<p style="top:133.1pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Mar 2013</span></p>
<p style="top:133.1pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Recruiting</span></p>
<p style="top:151.1pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT00765518</span></p>
<p style="top:160.1pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">(IMPACT-DCM)</span></p>
<p style="top:151.1pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:151.1pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Open-label</span></p>
<p style="top:151.1pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IM</span></p>
<p style="top:151.1pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CRC</span></p>
<p style="top:151.1pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Safety</span></p>
<p style="top:151.1pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Feb 2012</span></p>
<p style="top:151.1pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Completed</span></p>
<p style="top:169.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT01392625</span></p>
<p style="top:178.0pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">(POSEIDON-DCM)</span></p>
<p style="top:169.0pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:169.0pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Open-label</span></p>
<p style="top:169.0pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">TE</span></p>
<p style="top:169.0pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Autologous vs allogenic MSC</span></p>
<p style="top:169.0pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Safety</span></p>
<p style="top:169.0pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Jul 2015</span></p>
<p style="top:169.0pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Recruiting</span></p>
<p style="top:187.0pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT01020968</span></p>
<p style="top:187.0pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:187.0pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Open-label</span></p>
<p style="top:187.0pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">TE</span></p>
<p style="top:187.0pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">CRC</span></p>
<p style="top:187.0pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Safety</span></p>
<p style="top:187.0pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Feb 2012</span></p>
<p style="top:187.0pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Active, not</span></p>
<p style="top:195.9pt;left:515.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">recruiting</span></p>
<p style="top:204.9pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT00333827</span></p>
<p style="top:213.8pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">(MiHeart)</span></p>
<p style="top:204.9pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:204.9pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Double-blind</span></p>
<p style="top:204.9pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">IC</span></p>
<p style="top:204.9pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">BMC</span></p>
<p style="top:204.9pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">LVEF</span></p>
<p style="top:204.9pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Feb 2009</span></p>
<p style="top:204.9pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Unknown</span></p>
<p style="top:222.8pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">NCT00721045</span></p>
<p style="top:231.8pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">(Revascor)</span></p>
<p style="top:222.8pt;left:142.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT</span></p>
<p style="top:222.8pt;left:170.2pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Single-blind</span></p>
<p style="top:222.8pt;left:221.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">TE</span></p>
<p style="top:222.8pt;left:259.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">MPC</span></p>
<p style="top:222.8pt;left:365.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Safety</span></p>
<p style="top:222.8pt;left:462.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Jul 2011</span></p>
<p style="top:222.8pt;left:508.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Unknown</span></p>
<p style="top:249.6pt;left:52.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">RCT, randomized controlled trial; IC, intracoronary; IM, intramyocardial; TE, transendocardial; BM-MNC, bone marrow mononuclear cells; G-CSF, gran-</span></p>
<p style="top:258.6pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">ulocyte colony</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">stimulating factor; CRC, cardiac repair cells; BMC, bone marrow cells; MPC, mesynchymal precursor cells; MSC, mesenchymal stem cells;</span></p>
<p style="top:267.6pt;left:44.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">LVEF, left ventricular ejection fraction; MRI, magnetic resonance imaging.</span></p>
<p style="top:34.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">500</span></p>
<p style="top:35.7pt;left:70.1pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Journal of Cardiac Failure Vol. 19 No. 7 July 2013</span></p>


<p style="top:58.9pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">of ST-segment elevation myocardial infarction: a meta-analysis of</span></p>
<p style="top:68.9pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">randomized control trials. Eur J Heart Fail 2012;14:91</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">105</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:78.9pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">5. Centre for Evidence Based Medicine, Oxford University. EBM</span></p>
<p style="top:88.9pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">Tools. Critical appraisal sheets. Available at:</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> http://www.cebm.net/</span></p>
<p style="top:98.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">index.aspx?o</span><span style="font-family:AdvPS7DA6,serif;font-size:8.0pt;color:#000066">5</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">1157</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">. Accessed February 14, 2012.</span></p>
<p style="top:108.8pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">6.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Jin B, Luo XP, Ni HC, Li Y, Shi HM. Cardiac matrix remodeling fol-</span></p>
<p style="top:118.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">lowing intracoronary cell transplantation in dilated cardiomyopathic</span></p>
<p style="top:128.7pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">rabbits. Mol Biol Rep 2010;37:3037</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">42</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:138.7pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">7.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Dhein S, Garbade J, Rouabah D, Abraham G, Ungemach FR,</span></p>
<p style="top:148.6pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Schneider K, et al. Effects of autologous bone marrow stem cell</span></p>
<p style="top:158.6pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">transplantation on beta-adrenoceptor density and electrical activation</span></p>
<p style="top:168.5pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">pattern in a rabbit model of nonischemic heart failure. J Cardiothorac</span></p>
<p style="top:178.5pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Surg 2006;1:17</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:188.5pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">8.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> De Angelis A, Piegari E, Cappetta D, Marino L, Filippelli A,</span></p>
<p style="top:198.5pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Berrino L, et al. Anthracycline cardiomyopathy is mediated by deple-</span></p>
<p style="top:208.4pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">tion of the cardiac stem cell pool and is rescued by restoration of pro-</span></p>
<p style="top:218.4pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">genitor cell function. Circulation 2010;121:276</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">92</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:228.3pt;left:55.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">9.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Kondoh H, Sawa Y, Miyagawa S, Sakakida-Kitagawa S, Memon IA,</span></p>
<p style="top:238.3pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Kawaguchi N, et al. Longer preservation of cardiac performance by</span></p>
<p style="top:248.3pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">sheet-shaped myoblast implantation in dilated cardiomyopathic ham-</span></p>
<p style="top:258.2pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">sters. Cardiovasc Res 2006;69:466</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">75</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:268.2pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">10.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Yamada S, Nelson TJ, Crespo-Diaz RJ, Perez-Terzic C, Liu XK,</span></p>
<p style="top:278.2pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Miki T, et al. Embryonic stem cell therapy of heart failure in genetic</span></p>
<p style="top:288.1pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardiomyopathy. Stem Cells 2008;26:2644</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">53</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:298.1pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">11.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Baba S, Heike T, Yoshimoto M, Umeda K, Doi H, Iwasa T, et al.</span></p>
<p style="top:308.1pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Flk1</span><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">&#xfe;</span></sup><sup><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> </span></sup><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardiac stem/progenitor cells derived from embryonic stem</span></p>
<p style="top:318.0pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cells improve cardiac function in a dilated cardiomyopathy mouse</span></p>
<p style="top:327.9pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">model. Cardiovasc Res 2007;76:119</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">31</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:337.9pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">12.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Tezuka A, Kawada T, Nakazawa M, Masui F, Konno S, Nitta S, et al.</span></p>
<p style="top:347.9pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Which skeletal myoblasts and how to be transplanted for cardiac re-</span></p>
<p style="top:357.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">pair? Biochemical and biophysical research communications 2008;</span></p>
<p style="top:367.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">369:270</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:377.8pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">13.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Chen M, Fan ZC, Liu XJ, Deng JL, Yang Q, Huang DJ. Cell trans-</span></p>
<p style="top:387.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">plantation with a catheter-based approach: an ef&#xfb01;cient method for</span></p>
<p style="top:397.7pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">the treatment of heart failure with multiple lesions. Cell Prolif</span></p>
<p style="top:407.7pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">2006;39:471</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:417.6pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">14.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Ruengsakulrach P, Visudharom K, Chaothawee L, Belkin M. Periph-</span></p>
<p style="top:427.6pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">eral blood stem cell for cardiomyopathy. Bangkok Med J 2011;2:</span></p>
<p style="top:437.5pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">19</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">29</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:447.5pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">15.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Vrtovec B, Poglajen G, Lezaic L, Sever M, Domanovic D, Cernelc P,</span></p>
<p style="top:457.5pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Effects of intracoronary CD34</span><span style="font-family:AdvP4C4E74,serif;font-size:8.0pt;color:#000066">&#xfe;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> stem cell transplantation in</span></p>
<p style="top:467.4pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">nonischemic dilated cardiomyopathy patients: 5-year follow-up.</span></p>
<p style="top:477.4pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Circ Res 2013;112:165</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">73</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:487.4pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">16.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Su</span><span style="font-family:AdvP4C4E59,serif;font-size:8.0pt;color:#000066">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">arez de Lezo J, Herrera C, Romero M, Pan M, Su</span><span style="font-family:AdvP4C4E59,serif;font-size:8.0pt;color:#000066">&#xfffd;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">arez de Lezo J,</span></p>
<p style="top:497.4pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Carmona MD, et al. Functional improvement in patients with dilated</span></p>
<p style="top:507.3pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardiomyopathy after the intracoronary infusion of autologous bone</span></p>
<p style="top:517.3pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">marrow mononuclear cells. Rev Esp Cardiol 2013;66:450</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:527.2pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">17.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Fatkhutdinov T, d&#x2019;Yachkov AV, Koroteyev AV, Goldstein DV,</span></p>
<p style="top:537.2pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Bochkov NP. Safety and ef&#xfb01;ciency of transplantation of allogenic</span></p>
<p style="top:547.1pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">multipotent stromal cells in surgical treatment of dilatated cardiomy-</span></p>
<p style="top:557.1pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">opathy. Bull Exp Biol Med 2010;149:119</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">24</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:567.1pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">18.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Schannwell CM, K</span><span style="font-family:AdvP4C4E59,serif;font-size:8.0pt;color:#000066">&#x20ac;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">ostering M, Zeus T, Brehm M, Erdmann G,</span></p>
<p style="top:577.0pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Fleissner T, et al. [Humane autologe intrakoronare stammzelltrans-</span></p>
<p style="top:587.0pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">plantation zur myokardregeneration bei dilatativer cardiomyopathie</span></p>
<p style="top:597.0pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">(NYHA stadium II-IV)]. The D</span><span style="font-family:AdvP4C4E59,serif;font-size:8.0pt;color:#000066">&#x20ac;</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">usseldorf Autologous Bone Marrow</span></p>
<p style="top:607.0pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Cells in Dilated Cardiomyopathy Trial. ABCD Trial. J Kardiol</span></p>
<p style="top:616.9pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">2008;15:23</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">30. German</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:626.9pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">19.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Benetti F, Penherrera E, Maldonado T, Vera YD, Subramanian V,</span></p>
<p style="top:636.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Geffner L. Direct myocardial implantation of human fetal stem cells</span></p>
<p style="top:646.8pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">in heart failure patients: long-term results. Heart Surg Forum 2010;</span></p>
<p style="top:656.7pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">13:E31</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">5</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:666.7pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">20.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Martino HF, Oliveira PS, Souza FC, Costa PC, Assuncao ESE,</span></p>
<p style="top:676.7pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Villela R, et al. A safety and feasibility study of cell therapy in di-</span></p>
<p style="top:686.6pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">lated cardiomyopathy. Braz J Med Biol Res 2010;43:989</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">95</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:696.6pt;left:51.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">21.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Seth S, Bhargava B, Narang R, Ray R, Mohanty S, Gulati G, et al.</span></p>
<p style="top:706.6pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">The ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyop-</span></p>
<p style="top:716.6pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">athy) trial: a long-term follow-up study. J Am Coll Cardiol 2010;55:</span></p>
<p style="top:726.5pt;left:65.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">1643</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">4</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:59.0pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">22.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Vrtovec B, Poglajen G, Sever M, Lezaic L, Domanovic D, Cernelc P,</span></p>
<p style="top:69.0pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Effects of intracoronary stem cell transplantation in patients</span></p>
<p style="top:78.9pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">with dilated cardiomyopathy. J Card Fail 2011;17:272</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">81</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:88.9pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">23.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Arguero</span></p>
<p style="top:88.9pt;left:362.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">R,</span></p>
<p style="top:88.9pt;left:377.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Careaga-Reyna</span></p>
<p style="top:88.9pt;left:434.4pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">G,</span></p>
<p style="top:88.9pt;left:449.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Castano-Guerra</span></p>
<p style="top:88.9pt;left:507.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">R,</span></p>
<p style="top:88.9pt;left:522.6pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Garrido-</span></p>
<p style="top:98.8pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Garduno MH, Magana-Serrano JA, de Jesus Nambo</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Lucio M.</span></p>
<p style="top:108.8pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Cellular autotransplantation for ischemic and idiopathic dilated car-</span></p>
<p style="top:118.7pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">diomyopathy. Preliminary report. Arch Med Res 2006;37:1010</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">4</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:128.7pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">24.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Chin SP, Poey AC, Wong CY, Chang SK, Tan CS, Ng MT, et al. In-</span></p>
<p style="top:138.6pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">tramyocardial and intracoronary autologous bone marrow</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">derived</span></p>
<p style="top:148.6pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">mesenchymal stromal cell treatment in chronic severe dilated cardio-</span></p>
<p style="top:158.6pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">myopathy. Cytotherapy 2011;13:814</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">21</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:168.5pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">25.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Kirillov</span></p>
<p style="top:168.5pt;left:361.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">AM,</span></p>
<p style="top:168.5pt;left:383.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Fatkhudinov</span></p>
<p style="top:168.5pt;left:430.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">T,</span></p>
<p style="top:168.5pt;left:443.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Dyachkov</span></p>
<p style="top:168.5pt;left:483.5pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">AV,</span></p>
<p style="top:168.5pt;left:502.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Koroteev</span></p>
<p style="top:168.5pt;left:538.5pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">AV,</span></p>
<p style="top:178.5pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Goldshtein DV, Bochkov NP. Transplantation of allogenic cells in</span></p>
<p style="top:188.5pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">the therapy of patients with dilated cardiomyopathy. Bull Exp Biol</span></p>
<p style="top:198.5pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Med 2007;144:635</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">9</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:208.4pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">26.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Fischer-Rasokat U, Assmus B, Seeger FH, Honold J, Leistner D,</span></p>
<p style="top:218.4pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Fichtlscherer S, et al. A pilot trial to assess potential effects of selec-</span></p>
<p style="top:228.3pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">tive intracoronary bone marrow-derived progenitor cell infusion in</span></p>
<p style="top:238.3pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">patients with nonischemic dilated cardiomyopathy: &#xfb01;nal 1-year re-</span></p>
<p style="top:248.2pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">sults of the transplantation of progenitor cells and functional regen-</span></p>
<p style="top:258.2pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">eration enhancement pilot trial in patients with nonischemic dilated</span></p>
<p style="top:268.2pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardiomyopathy. Circ Heart Fail 2009;2:417</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">23</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:278.2pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">27.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Bocchi EA, Bacal F, Guimaraes G, Mendroni A, Mocelin A, Filho AE,</span></p>
<p style="top:288.1pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Granulocyte-colony stimulating factor or granulocyte-colony</span></p>
<p style="top:298.1pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">stimulating factor associated to stem cell intracoronary infusion effects</span></p>
<p style="top:308.1pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">in non ischemic refractory heart failure. Int J Cardiol 2010;138:94</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:318.0pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">28.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Kalil RA, Ott D, Sant&#x2019;Anna R, Dias E, Marques-Pereira JP, Delgado-</span></p>
<p style="top:328.0pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Canedo A, et al. Autologous transplantation of bone marrow mono-</span></p>
<p style="top:337.9pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">nuclear stem cells by mini-thoracotomy in dilated cardiomyopathy:</span></p>
<p style="top:347.9pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">technique and early results. Sao Paulo Med J 2008;126:75</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">81</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:357.8pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">29.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Hata H, Matsumiya G, Miyagawa S, Kondoh H, Kawaguchi N,</span></p>
<p style="top:367.8pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Matsuura N, et al. Grafted skeletal myoblast sheets attenuate myocar-</span></p>
<p style="top:377.8pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">dial remodeling in pacing-induced canine heart failure model. J Thor-</span></p>
<p style="top:387.8pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">ac Cardiovasc Surg 2006;132:918</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">24</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:397.7pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">30.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Psaltis PJ, Carbone A, Nelson AJ, Lau DH, Jantzen T, Manavis J,</span></p>
<p style="top:407.7pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Reparative effects of allogeneic mesenchymal precursor cells</span></p>
<p style="top:417.7pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">delivered transendocardially in experimental nonischemic cardiomy-</span></p>
<p style="top:427.6pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">opathy. JACC Cardiovasc interv 2010;3:974</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">83</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:437.6pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">31.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Bartunek</span></p>
<p style="top:437.6pt;left:365.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">J,</span></p>
<p style="top:437.6pt;left:378.6pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Dimmeler</span></p>
<p style="top:437.6pt;left:418.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">S,</span></p>
<p style="top:437.6pt;left:432.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Drexler</span></p>
<p style="top:437.6pt;left:464.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">H,</span></p>
<p style="top:437.6pt;left:480.3pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Fernandez-Aviles</span></p>
<p style="top:447.5pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Galinanes M, Janssens S, et al. The consensus of the Task Force of</span><sup><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">F,</span></sup></p>
<p style="top:457.5pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">the European Society of Cardiology concerning the clinical investi-</span></p>
<p style="top:467.4pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">gation of the use of autologous adult stem cells for repair of the heart.</span></p>
<p style="top:477.4pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Eur Heart J 2006;27:1338</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">40</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:487.4pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">32.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Widimsky P, Penicka M. Complications after intracoronary stem cell</span></p>
<p style="top:497.4pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">transplantation in idiopathic dilated cardiomyopathy. Int J Cardiol</span></p>
<p style="top:507.3pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">2006;111:178</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">9</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:517.3pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">33.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Marwick TH, Raman SV, Carrio I, Bax JJ. Recent developments in</span></p>
<p style="top:527.3pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">heart failure imaging. JACC Cardiovasc Imaging 2010;3:429</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">39</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:537.2pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">34.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> van Slochteren FJ, Teske AJ, van der Spoel TI, Koudstaal S,</span></p>
<p style="top:547.2pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Doevendans PA, Sluijter JP, et al. Advanced measurement techniques</span></p>
<p style="top:557.1pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">of regional myocardial function to assess the effects of cardiac regen-</span></p>
<p style="top:567.1pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">erative therapy in different models of ischaemic cardiomyopathy. Eur</span></p>
<p style="top:577.0pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Heart J Cardiovasc Imaging 2012;13:808</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">18</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:587.0pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">35.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature</span></p>
<p style="top:597.0pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">2008;451:937</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">42</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:607.0pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">36.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Maxeiner H, Krehbiehl N, Muller A, Woitasky N, Akinturk H,</span></p>
<p style="top:616.9pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Muller M, et al. New insights into paracrine mechanisms of human</span></p>
<p style="top:626.9pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardiac progenitor cells. Eur J Heart Fail 2010;12:730</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:636.9pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">37.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Roura S, Bayes-Genis A. Vascular dysfunction in idiopathic dilated</span></p>
<p style="top:646.8pt;left:328.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardiomyopathy. Nat Rev Cardiol 2009;6:590</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">8</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:656.8pt;left:314.9pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">38.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Jessup M, Greenberg B, Mancini D, Cappola T, Pauly DF, Jaski B,</span></p>
<p style="top:666.7pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Calcium Upregulation by Percutaneous Administration of</span></p>
<p style="top:676.7pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Gene Therapy in Cardiac Disease (CUPID): a phase 2 trial of intra-</span></p>
<p style="top:686.6pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">coronary gene therapy of sarcoplasmic reticulum Ca</span><sup><span style="font-family:AdvPSA88A,serif;font-size:5.6pt;color:#000066">2</span></sup><sup><span style="font-family:AdvP4C4E74,serif;font-size:5.6pt;color:#000066">&#xfe;</span></sup><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">-ATPase in pa-</span></p>
<p style="top:696.6pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">tients with advanced heart failure. Circulation 2011;124:304</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">13</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:706.5pt;left:314.8pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">39.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Sun N, Yazawa M, Liu J, Han L, Sanchez-Freire V, Abilez OJ, et al.</span></p>
<p style="top:716.5pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Patient-speci&#xfb01;c induced pluripotent stem cells as a model for familial</span></p>
<p style="top:726.4pt;left:328.7pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">dilated cardiomyopathy. Sci Transl Med 2012;4:130ra47</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:34.9pt;left:298.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Cell Therapy for Dilated Cardiomyopathy</span><span style="font-family:AdvP4C4E74,serif;font-size:13.0pt"> &#xfffd;</span></p>
<p style="top:34.9pt;left:486.9pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Gho et al</span></p>
<p style="top:34.2pt;left:533.4pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">501</span></p>


<p style="top:58.9pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">40.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P,</span></p>
<p style="top:68.9pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Classi&#xfb01;cation of the cardiomyopathies: a position statement</span></p>
<p style="top:78.9pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">from the European Society of Cardiology Working Group on Myo-</span></p>
<p style="top:88.9pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cardial and Pericardial Diseases. Eur Heart J 2008;29:270</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:98.8pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">41.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Chen Y, Liu W, Li W, Gao C. Autologous bone marrow mesenchy-</span></p>
<p style="top:108.8pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">mal cell transplantation improves left ventricular function in a rabbit</span></p>
<p style="top:118.8pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">model of dilated cardiomyopathy. Exp Mol Pathol 2010;88:311</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">5</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:128.7pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">42.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Garbade J, Dhein S, Lipinski C, Aupperle H, Arsalan M, Borger MA,</span></p>
<p style="top:138.7pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Bone marrow</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">derived stem cells attenuate impaired contractil-</span></p>
<p style="top:148.6pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">ity and enhance capillary density in a rabbit model of Doxorubicin-</span></p>
<p style="top:158.6pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">induced failing hearts. J Card Surg 2009;24:591</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">9</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:168.5pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">43.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Ishida M, Tomita S, Nakatani T, Fukuhara S, Hamamoto M,</span></p>
<p style="top:178.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Nagaya N, et al. Bone marrow mononuclear cell transplantation</span></p>
<p style="top:188.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">had bene&#xfb01;cial effects on doxorubicin-induced cardiomyopathy. J</span></p>
<p style="top:198.5pt;left:62.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Heart Lung Transplant 2004;23:436</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">45</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:208.4pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">44.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Kondoh H, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Kita-</span></p>
<p style="top:218.4pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">gawa-Sakakida S, et al. Combined strategy using myoblasts and he-</span></p>
<p style="top:228.3pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">patocyte growth factor in dilated cardiomyopathic hamsters. Ann</span></p>
<p style="top:238.3pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Thorac Surg 2007;84:134</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">41</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:248.3pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">45.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Lin YC, Leu S, Sun CK, Yen CH, Kao YH, Chang LT, et al. Early</span></p>
<p style="top:258.2pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">combined treatment with sildena&#xfb01;l and adipose-derived mesenchy-</span></p>
<p style="top:268.2pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">mal stem cells preserves heart function in rat dilated cardiomyopathy.</span></p>
<p style="top:278.2pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">J Transl Med 2010;8:88</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:288.1pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">46.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Lu C, Arai M, Misao Y, Chen X, Wang N, Onogi H, et al. Autologous</span></p>
<p style="top:298.1pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">bone marrow cell transplantation improves left ventricular function</span></p>
<p style="top:308.1pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">in rabbit hearts with cardiomyopathy via myocardial regeneration-</span></p>
<p style="top:318.0pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">unrelated mechanisms. Heart Vessels 2006;21:180</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:328.0pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">47.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Mu Y, Cao G, Zeng Q, Li Y. Transplantation of induced bone marrow</span></p>
<p style="top:337.9pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">mesenchymal stem cells improves the cardiac function of rabbits</span></p>
<p style="top:347.9pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">with dilated cardiomyopathy via upregulation of vascular endothelial</span></p>
<p style="top:357.8pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">growth factor and its receptors. Exp Biol Med (Maywood) 2011;236:</span></p>
<p style="top:367.8pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">1100</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:377.8pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">48.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Nagaya N, Kangawa K, Itoh T, Iwase T, Murakami S, Miyahara Y,</span></p>
<p style="top:387.8pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Transplantation of mesenchymal stem cells improves cardiac</span></p>
<p style="top:397.7pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">function in a rat model of dilated cardiomyopathy. Circulation</span></p>
<p style="top:407.7pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">2005;112:1128</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">35</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:417.7pt;left:48.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">49.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Nakajima H, Sakakibara Y, Tambara K, Marui A, Yoshimoto M,</span></p>
<p style="top:427.6pt;left:62.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Premaratne GU, et al. Delivery route in bone marrow cell</span></p>
<p style="top:59.0pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">transplantation should be optimized according to the etiology of heart</span></p>
<p style="top:68.9pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">disease. Circ J 2008;72:1528</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">35</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:78.9pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">50.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Nomura T, Ashihara E, Tateishi K, Asada S, Ueyama T, Takahashi T,</span></p>
<p style="top:88.9pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">et al. Skeletal myosphere-derived progenitor cell transplantation pro-</span></p>
<p style="top:98.8pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">motes neovascularization in delta-sarcoglycan knockdown cardiomy-</span></p>
<p style="top:108.8pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">opathy. Biochem Biophys Res Commun 2007;352:668</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">74</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:118.8pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">51.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Ohno N, Fedak PW, Weisel RD, Mickle DA, Fujii T, Li RK. Trans-</span></p>
<p style="top:128.8pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">plantation of cryopreserved muscle cells in dilated cardiomyopathy:</span></p>
<p style="top:138.7pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">effects on left ventricular geometry and function. J Thorac Cardio-</span></p>
<p style="top:148.7pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">vasc Surg 2003;126:1537</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">48</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:158.6pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">52.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Pouly J, Hagege AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, et al.</span></p>
<p style="top:168.6pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Does the functional ef&#xfb01;cacy of skeletal myoblast transplantation extend</span></p>
<p style="top:178.5pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">to nonischemic cardiomyopathy? Circulation 2004;110:1626</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">31</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:188.5pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">53.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Shabbir A, Zisa D, Suzuki G, Lee T. Heart failure therapy mediated</span></p>
<p style="top:198.5pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">by the trophic activities of bone marrow mesenchymal stem cells:</span></p>
<p style="top:208.4pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">a noninvasive therapeutic regimen. Am J Physiol Heart Circ Physiol</span></p>
<p style="top:218.4pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">2009;296:H1888</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">97</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:228.4pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">54.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Singla DK, Ahmed A, Singla R, Yan B. Embryonic stem cells im-</span></p>
<p style="top:238.4pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">prove cardiac function in doxorubicin-induced cardiomyopathy me-</span></p>
<p style="top:248.3pt;left:325.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">diated through multiple mechanisms. Cell Transplant 2012;21:</span></p>
<p style="top:258.2pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">1919</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">30</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:268.2pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">55.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Sun CK, Chang LT, Sheu JJ, Chiang CH, Lee FY, Wu CJ, et al. Bone</span></p>
<p style="top:278.2pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">marrow</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">derived mononuclear cell therapy alleviates left ventricular</span></p>
<p style="top:288.1pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">remodeling and improves heart function in rat-dilated cardiomyopa-</span></p>
<p style="top:298.1pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">thy. Crit Care Med 2009;37:1197</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">205</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:308.0pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">56.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Suzuki K, Murtuza B, Suzuki N, Smolenski RT, Yacoub MH. Intra-</span></p>
<p style="top:318.0pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">coronary infusion of skeletal myoblasts improves cardiac function in</span></p>
<p style="top:328.0pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">doxorubicin-induced heart failure. Circulation 2001;104:I213</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:337.9pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">57.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Werner L, Deutsch V, Barshack I, Miller H, Keren G, George J.</span></p>
<p style="top:347.9pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">Transfer of endothelial progenitor cells improves myocardial perfor-</span></p>
<p style="top:357.8pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">mance in rats with dilated cardiomyopathy induced following exper-</span></p>
<p style="top:367.8pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">imental myocarditis. J Mol Cell Cardiol 2005;39:691</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">7</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:377.8pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">58.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Zhang J, Li GS, Li GC, Zhou Q, Li WQ, Xu HX. Autologous mes-</span></p>
<p style="top:387.8pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">enchymal stem cells transplantation in adriamycin-induced cardio-</span></p>
<p style="top:397.7pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">myopathy. Chin Med J (Engl) 2005;118:73</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">6</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:407.7pt;left:311.1pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">59.</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066"> Zhou C, Yang C, Xiao S, Fei H. Feasibility of bone marrow stromal</span></p>
<p style="top:417.6pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">cells autologous transplantation for dilated cardiomyopathy. J Huaz-</span></p>
<p style="top:427.6pt;left:325.0pt;line-height:8.0pt"><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">hong Univ Sci Technolog Med Sci 2007;27:75</span><span style="font-family:AdvPS44A44B,serif;font-size:8.0pt;color:#000066">e</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt;color:#000066">8</span><span style="font-family:AdvPSA88A,serif;font-size:8.0pt">.</span></p>
<p style="top:34.9pt;left:44.1pt;line-height:10.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:10.0pt">502</span></p>
<p style="top:35.7pt;left:70.1pt;line-height:9.0pt"><span style="font-family:AdvPS6EC0,serif;font-size:9.0pt">Journal of Cardiac Failure Vol. 19 No. 7 July 2013</span></p>

</div>
